var title_f0_30_480="Traumatic cataract";
var content_f0_30_480=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Traumatic cataract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A photograph of a patient following blunt trauma showing traumatic cataract. Retroillumation of the lens demonstrates posterior-subcapsular opacification of the lens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Kathryn A. Colby, MD, PhD, Massachusetts Eye and Ear Infirmary, Boston.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_480=[""].join("\n");
var outline_f0_30_480=null;
var title_f0_30_481="LIP CT scan";
var content_f0_30_481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F65519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F65519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphocytic interstitial pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prone&nbsp;high resolution computed tomography (HRCT) scan&nbsp;shows diffuse ground glass attenuation with multiple lung cysts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_481=[""].join("\n");
var outline_f0_30_481=null;
var title_f0_30_482="Patient information: Serotonin syndrome (The Basics)";
var content_f0_30_482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/57/12179\">",
"         Patient information: Depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/6/24675\">",
"         Patient information: Medicines for depression (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?19/41/20116\">",
"         Patient information: Depression in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/24/21894\">",
"         Patient information: Depression treatment options for adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Serotonin syndrome (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H630547279\">",
"      <span class=\"h1\">",
"       What is serotonin syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Serotonin syndrome is a serious problem that can cause a number of symptoms, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Anxiety, restlessness, or confusion",
"       </li>",
"       <li>",
"        Sweating",
"       </li>",
"       <li>",
"        Muscle spasms and muscle rigidity",
"       </li>",
"       <li>",
"        Rapid back and forth eye movements",
"       </li>",
"       <li>",
"        Shaking or trembling",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Rapid heart rate",
"       </li>",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547294\">",
"      <span class=\"h1\">",
"       What causes serotonin syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Serotonin syndrome happens to people after they take certain medicines or combinations of medicines. It can also happen with certain herbal products and street drugs. There are many medicines and drugs that can lead to serotonin syndrome. In general, they all affect a chemical in the brain and body called &ldquo;serotonin.&rdquo;",
"     </p>",
"     <p>",
"      Examples of the medicines and drugs that can cause serotonin syndrome include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Antidepressants",
"       </li>",
"       <li>",
"        Some pain relievers, such as",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?23/46/24293?source=see_link\">",
"         meperidine",
"        </a>",
"        (brand name: Demerol),",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?30/5/30805?source=see_link\">",
"         tramadol",
"        </a>",
"        (brand name: Ultram), and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?32/23/33140?source=see_link\">",
"         cyclobenzaprine",
"        </a>",
"        (brand name: Flexeril)",
"       </li>",
"       <li>",
"        Saint John&rsquo;s wort (an herbal medicine used to treat depression)",
"       </li>",
"       <li>",
"        Medicines used to treat migraine headaches, called &ldquo;triptans&rdquo;",
"       </li>",
"       <li>",
"        Street drugs, such as ecstasy, cocaine, and amphetamines",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Doctors do not know why some people get serotonin syndrome and others do not. But they do know that people usually develop it within hours of taking a new medicine or drug, a new dose, or a new combination of medicines or drugs.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547309\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have symptoms of serotonin syndrome, and you recently took a new drug or medicine or a new dose, call your doctor right away. If your symptoms are severe go to the emergency room or call 9-1-1 for an ambulance.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547324\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. There is no single test that can show whether or not you have serotonin syndrome. Still, some of the things the doctor will do during the exam can help him or her figure out if you have it. For instance, the doctor might test your leg muscles to see if they spasm. The doctor will also ask a lot of questions about any medicines, herbal products, or street drugs you might have taken.",
"     </p>",
"     <p>",
"      If you have serotonin syndrome, it&rsquo;s very important that you be honest with your doctor about what you took, how much, and when.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547339\">",
"      <span class=\"h1\">",
"       How is serotonin syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;As part of treatment, the doctor will stop the medicines or drugs that caused the serotonin syndrome in the first place. He or she will also monitor your breathing, heart rate, blood pressure, and body temperature, and try to keep these as close to normal as possible.",
"     </p>",
"     <p>",
"      Depending on what you need, he or she might also:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Give you medicines to calm you",
"       </li>",
"       <li>",
"        Give you medicines to block the effects of serotonin",
"       </li>",
"       <li>",
"        Work with you to decide whether you should keep taking the medicines that caused your serotonin syndrome",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547354\">",
"      <span class=\"h1\">",
"       Can serotonin syndrome be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No, but there are things you can do to protect yourself.",
"     </p>",
"     <p>",
"      Doctors have no way to predict who will get serotonin syndrome, so it&rsquo;s not possible to prevent cases caused by properly prescribed medicines. Even so, there are things you can do to protect yourself from dangerous reactions to medicines:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Always tell any doctor who prescribes medicines for you about ALL the medicines, herbal products, and street drugs you take. That way, the doctor can be careful not to give you medicines that could cause problems when combined.",
"       </li>",
"       <li>",
"        When starting a new medicine, have the pharmacist check for drug interactions and double-check that you are taking the right amount.",
"       </li>",
"       <li>",
"        If you are already on medicine, do not take a new herbal or over-the-counter medicine without first checking with your doctor, nurse, or pharmacist.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H630547369\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=see_link\">",
"       Patient information: Medicines for depression (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=see_link\">",
"       Patient information: Depression (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       Patient information: Depression in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"       Patient information: Depression treatment options for adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?0/30/482?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87578 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-59E8FFCE15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_482=[""].join("\n");
var outline_f0_30_482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547279\">",
"      What is serotonin syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547294\">",
"      What causes serotonin syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547309\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547324\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547339\">",
"      How is serotonin syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547354\">",
"      Can serotonin syndrome be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630547369\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=related_link\">",
"      Patient information: Depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=related_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=related_link\">",
"      Patient information: Medicines for depression (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_483="Patient information: Dealing with side effects from medicines (The Basics)";
var content_f0_30_483=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16828\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19066\">",
"         The different parts of a medicine label (Drug Facts)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?23/3/23603\">",
"         Patient information: Drug allergy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/16/34050\">",
"         Patient information: Going home from the hospital (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/43/37554\">",
"         Patient information: Medicine brand and generic names (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/38/12898\">",
"         Patient information: Stevens-Johnson syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/34/32290\">",
"         Patient information: Taking medicines when you're older (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/61/32726\">",
"         Patient information: Reducing the costs of medicines (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Dealing with side effects from medicines (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/dealing-with-side-effects-from-medicines-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H8525907\">",
"      <span class=\"h1\">",
"       What are side effects?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Side effects are unintended or unwanted effects that medicines can cause. Not everyone gets side effects, but many people do. Sometimes side effects can be a problem because they keep people from taking medicines they need. If side effects are a problem for you, you should know there are often ways to avoid, reduce, or manage side effects. &nbsp;",
"     </p>",
"     <p>",
"      Some of the more common side effects of medicines include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Dizziness",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Upset stomach, diarrhea, or constipation",
"       </li>",
"       <li>",
"        Increased or decreased appetite",
"       </li>",
"       <li>",
"        Trouble sleeping",
"       </li>",
"       <li>",
"        Dry mouth",
"       </li>",
"       <li>",
"        Dry cough that doesn&rsquo;t go away",
"       </li>",
"       <li>",
"        Skin rashes",
"       </li>",
"       <li>",
"        Feeling tired or sleepy, or getting tired easily",
"       </li>",
"       <li>",
"        Feeling sad, depressed, anxious or jittery",
"       </li>",
"       <li>",
"        Sex problems",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8525922\">",
"      <span class=\"h1\">",
"       What should I do if my medicines cause side effects?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on how serious the side effects are. Most side effects are annoying but not really dangerous. On the other hand, some side effects can be very dangerous or even life threatening. For example, people can have severe allergic reactions to medicines, which can kill them.",
"     </p>",
"     <p>",
"      <strong>",
"       Call 9-1-1",
"      </strong>",
"      for an ambulance if you start a new medicine and develop any of the symptoms listed below:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Wheezing or trouble breathing",
"       </li>",
"       <li>",
"        Chest tightness or pain",
"       </li>",
"       <li>",
"        Passing out or feeling as if you will pass out",
"       </li>",
"       <li>",
"        Swelling of your face, lips, tongue, or throat",
"       </li>",
"       <li>",
"        Seizures",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Call your doctor if you start a new medicine and develop any of the symptoms listed below:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hives (raised red welts on the skin that are usually very itchy)",
"       </li>",
"       <li>",
"        Feeling like you want to hurt or kill yourself",
"       </li>",
"       <li>",
"        Severe stomach ache or vomiting",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8525945\">",
"      <span class=\"h1\">",
"       What if I have side effects that annoy me but aren&rsquo;t dangerous?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have annoying side effects, talk to your doctor, nurse, or pharmacist. Do not simply stop taking the medicine that you think is causing the problem. The medicine might be very important for your health and well-being. Plus, stopping the medicine might cause other problems. Your doctor or nurse can work with you to reduce or manage your side effects. &nbsp;",
"     </p>",
"     <p>",
"      Your doctor or nurse can help you figure out if the symptoms you are having are really side effects of your medicines, or whether they are caused by something else. If it turns out your symptoms are actually side effects, your doctor or nurse might be able to lower your dose or switch you to a different medicine that doesn't cause the same problems.",
"     </p>",
"     <p>",
"      Even if the side effects you have can't be avoided, it's still important to talk to your doctor or nurse. He or she might be able to help you understand why the medicine you are taking is worth it even if it causes side effects. Besides, there might be other ways to fix your problem.",
"     </p>",
"     <p>",
"      Here are some things you should know about dealing with your side effects:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Some side effects go away over time",
"        </strong>",
"        , as your body gets used to the medicine. For example, medicines to treat depression can bother your stomach for a while but that side effect goes away after 1 or 2 weeks.",
"       </li>",
"       <li>",
"        <strong>",
"         People often learn to manage side effects",
"        </strong>",
"        , or find ways to take their medicines so they cause fewer problems. For example, some medicines can make you feel sleepy, but if you take them just before bed, the side effect is less of a problem. Sometimes side effects depend on whether you take the medicine with food, what time you take it, or whether you combine it with alcohol or other medicines. If this is true for the side effects you have, your doctor or pharmacist can give you advice on what to do to manage them.",
"       </li>",
"       <li>",
"        <strong>",
"         Sometimes you can change your diet or take another medicine to deal with a side effect",
"        </strong>",
"        . For example, if a pain medicine makes you constipated, you can eat more fiber, drink more water, and use a stool softener. Or if a blood pressure medicine or antidepressant causes sexual problems, you might be able to take another medicine to improve sex.",
"       </li>",
"       <li>",
"        <strong>",
"         Side effects can sometimes be important clues about what your medicines are doing to your body.",
"        </strong>",
"        Having certain side effects can mean that a medicine is harming your body, for example by stressing your liver. This is another reason it is so important to tell your doctor or nurse about any side effects you have.",
"       </li>",
"       <li>",
"        <strong>",
"         Not taking your medicines correctly can cause side effects.",
"        </strong>",
"        People sometimes bring on side effects by missing doses, taking medicines at the wrong times, or taking too much medicine. People can also bring on side effects if they don&rsquo;t follow the instructions on how to take medicines. Take your medicines exactly as prescribed.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8525962\">",
"      <span class=\"h1\">",
"       How can I find out the known side effects of my medicines?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are a few different ways you can find this out:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Ask your doctor or nurse what side effects to expect when he or she prescribes the medicines. Ask also what you should do if you have any side effects.",
"       </li>",
"       <li>",
"        Ask your pharmacist about the side effects when you get your prescriptions filled. Ask also what you should do if you have any side effects.",
"       </li>",
"       <li>",
"        Read the printed materials that come with the medicine (",
"        <a class=\"graphic graphic_figure graphicRef73468 \" href=\"UTD.htm?18/39/19066\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Check online at FDA.gov for information about the medicine.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      For more detailed information about your medicines, ask your doctor or nurse for information from Lexicomp available through UpToDate. The Lexicomp hand-outs explain how to use and store your medicines. They also list possible side effects and warn you if your medicines should not be taken with certain other medicines or foods.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8525977\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=see_link\">",
"       Patient information: Taking medicines when you're older (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=see_link\">",
"       Patient information: Medicine brand and generic names (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=see_link\">",
"       Patient information: Going home from the hospital (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/38/12898?source=see_link\">",
"       Patient information: Stevens-Johnson syndrome (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/3/23603?source=see_link\">",
"       Patient information: Drug allergy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       Patient information: Reducing the costs of medicines (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?0/30/483?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16828 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_483=[""].join("\n");
var outline_f0_30_483=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8525907\">",
"      What are side effects?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8525922\">",
"      What should I do if my medicines cause side effects?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8525945\">",
"      What if I have side effects that annoy me but aren&rsquo;t dangerous?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8525962\">",
"      How can I find out the known side effects of my medicines?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8525977\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16828\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/39/19066\">",
"      The different parts of a medicine label (Drug Facts)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/3/23603?source=related_link\">",
"      Patient information: Drug allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/16/34050?source=related_link\">",
"      Patient information: Going home from the hospital (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=related_link\">",
"      Patient information: Medicine brand and generic names (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/38/12898?source=related_link\">",
"      Patient information: Stevens-Johnson syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=related_link\">",
"      Patient information: Taking medicines when you're older (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_484="Ofloxacin (otic): Drug information";
var content_f0_30_484=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ofloxacin (otic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/6/16484?source=see_link\">",
"    see \"Ofloxacin (otic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/42/20131?source=see_link\">",
"    see \"Ofloxacin (otic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9498000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibacterial, Otic;",
"     </li>",
"     <li>",
"      Antibiotic, Quinolone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9497841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Otitis media, chronic suppurative with perforated tympanic membranes:",
"     </b>",
"     Otic: Instill 10 drops (or the contents of 2 single-dose containers) into affected ear twice daily for 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Otitis externa:",
"     </b>",
"     Otic: Instill 10 drops (or the contents of 2 single-dose containers) into affected ear(s) once daily for 7 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9497840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/42/20131?source=see_link\">",
"      see \"Ofloxacin (otic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not for systemic use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute otitis media with tympanotomy tubes:",
"     </b>",
"     Otic: Children 1-12 years: Instill 5 drops (or the contents of 1 single-dose container) into affected ear twice daily for 10 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Otitis externa:",
"     </b>",
"     Otic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6 months to 13 years: Instill 5 drops (or the contents of 1 single-dose container) into affected ear(s) once daily for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;13 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Otitis media, chronic suppurative with perforated tympanic membranes:",
"     </b>",
"     Otic: Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9497976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, otic [drops]: 0.3% (5 mL, 10 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9496349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9497905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Prior to use, warm solution by holding container in hands for 1-2 minutes. Patient should lie down with affected ear upward and medication instilled. Pump tragus 4 times to ensure penetration of medication. Patient should remain in this position for 5 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9496350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Otitis externa, chronic suppurative otitis media, acute otitis media",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9496297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Floxin may be confused with Flexeril&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Floxin: Brand name for ofloxacin [U.S., Canada], but also the brand name for flunarizine [Thailand], norfloxacin [South Africa], and perfloxacin [Philippines]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Floxin [U.S., Canada] may be confused with Flexin brand name for diclofenac [Argentina], cyclobenzaprine [Chile], and orphenadrine [Israel]; Flogen brand name for naproxen [Mexico]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9497565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Local: Application site reaction (&lt;1% to 17%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (&le;1%), vertigo (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus (1% to 4%), rash (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Taste perversion (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Diarrhea, fever, headache, hearing loss (transient), hypertension, nausea, otorrhagia, tinnitus, transient neuropsychiatric disturbances, tremor, vomiting, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9497552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ofloxacin or other members of the quinolone group, such as oxolinic acid, cinoxacin, norfloxacin, and ciprofloxacin; hypersensitivity to any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9497553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Severe hypersensitivity reactions, including anaphylaxis, have occurred with quinolone therapy (primarily with systemic use). The spectrum of these reactions can vary widely; reactions may present as typical allergic symptoms (eg, itching, urticaria, rash, edema) after a single dose or may manifest as severe idiosyncratic dermatologic (eg, Stevens-Johnson, toxic epidermal necrolysis), vascular (eg, vasculitis), pulmonary (eg, pneumonitis), renal (eg, nephritis), hepatic (eg, hepatic failure or necrosis), and/or hematologic (eg, anemia, cytopenias) events, usually after multiple doses. Prompt discontinuation of drug should occur if skin rash or other symptoms arise.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection. If superinfection is suspected, institute appropriate alternative therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tendon inflammation/rupture: There have been reports of tendon inflammation and/or rupture with systemic quinolone antibiotics. Exposure following otic administration is substantially lower than with systemic therapy. Discontinue at first sign of tendon inflammation or pain.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Otic use: Not for injection or for ophthalmic use.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F9497665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9497666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9496359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9775942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal studies; therefore, the manufacturer classifies ofloxacin otic as pregnancy category C. When administered orally, ofloxacin crosses the placenta. Refer to the Ofloxacin (Systemic) monograph for details. The amount of ofloxacin available systemically following topical application of the otic drops is significantly less in comparison to oral doses.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9497527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended (AAP rates \"compatible\"; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F9497551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When administered orally, ofloxacin enters breast milk. Refer to the Ofloxacin (Systemic) monograph for details. The amount of ofloxacin available systemically following topical application of the otic drops is significantly less in comparison to oral doses; however, due to the potential for adverse events in a nursing infant, breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9497978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ofloxacin Otic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3% (5 mL): $74.00",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F14721645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anli (CL);",
"     </li>",
"     <li>",
"      Dizoflox (PH);",
"     </li>",
"     <li>",
"      Earflo Otic (TW);",
"     </li>",
"     <li>",
"      Inoflox (PH);",
"     </li>",
"     <li>",
"      Oflaxsyn (CO);",
"     </li>",
"     <li>",
"      Ofven (IN);",
"     </li>",
"     <li>",
"      Otoflox (AR, DO, EC);",
"     </li>",
"     <li>",
"      Otonil (PY);",
"     </li>",
"     <li>",
"      Tarivid (CL, HK, ID, KP, MY, SG, TW);",
"     </li>",
"     <li>",
"      Tructum (PE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9497805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ofloxacin is a DNA gyrase inhibitor. DNA gyrase is an essential bacterial enzyme that maintains the superhelical structure of DNA. DNA gyrase is required for DNA replication and transcription, DNA repair, recombination, and transposition; bactericidal",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9775940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Absorption: Only small amounts are absorbed systemically after otic instillation.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/30/484/abstract-text/11533352 /pubmed\" id=\"11533352 \" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9891 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C3286EAA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_484=[""].join("\n");
var outline_f0_30_484=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9498000\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497841\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497840\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497976\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9496349\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497905\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9496350\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9496297\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497565\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497552\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497553\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497665\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497666\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9496359\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9775942\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497527\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497551\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497978\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14721645\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9497805\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9775940\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9891\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9891|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/2/31780?source=related_link\">",
"      Ofloxacin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/20/30020?source=related_link\">",
"      Ofloxacin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/55/21363?source=related_link\">",
"      Ofloxacin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/6/16484?source=related_link\">",
"      Ofloxacin (otic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/42/20131?source=related_link\">",
"      Ofloxacin (otic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/41/1688?source=related_link\">",
"      Ofloxacin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/29/30165?source=related_link\">",
"      Ofloxacin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/28/34246?source=related_link\">",
"      Ofloxacin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_485="Exemestane: Patient drug information";
var content_f0_30_485=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Exemestane: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/4/7238?source=see_link\">",
"     see \"Exemestane: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aromasin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F169506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aromasin&reg;;",
"     </li>",
"     <li>",
"      CO Exemestane",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016428\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691764",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat breast cancer in women after change of life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3558634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3558635",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat some uterine cancers.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to exemestane or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703796",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have not stopped your period.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have soft, brittle bones (osteoporosis), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016433\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing. Wearing layers of clothes or summer clothes and staying in cool places may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698390",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weak bones with long-term use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695844",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take after a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016437\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12459 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-197.136.42.3-E1899EF4C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_485=[""].join("\n");
var outline_f0_30_485=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169505\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169506\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016428\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016427\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016432\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016433\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016435\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016430\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016431\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016436\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016437\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/4/7238?source=related_link\">",
"      Exemestane: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_486="Levodopa-benserazide: Drug information";
var content_f0_30_486=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Levodopa-benserazide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/17/18709?source=see_link\">",
"    see \"Levodopa-benserazide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F139718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Prolopa&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F139728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anti-Parkinson's Agent, Dopamine Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F139721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Parkinson's disease:",
"     </b>",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Dosage expressed as levodopa/benserazide. Dosage should be introduced gradually, individualized, and continued for 3-6 weeks before assessing benefit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Patients currently receiving levodopa therapy:",
"     </i>",
"     Discontinue levodopa &ge;12 hours prior to the initiation of therapy; start at 15% of previous levodopa dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Patients",
"      <b>",
"       NOT",
"      </b>",
"      on levodopa therapy:",
"     </i>",
"     Initial: 100/25 mg 1-2 times/day; increase dose by 100/25 mg every 3-4 days until therapeutic effect; usual optimal dosage: 400/100 mg to 800/200 mg divided into 4-6 doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     The 200/50 mg capsules should be used only when maintenance therapy is reached. The 50/12.5 mg capsules should be used to decrease adverse effects when adjusting dose. Total daily dose during the first year of therapy should not exceed 1000-1200 mg of levodopa. After 1 year of therapy, the maximum recommended daily dose of levodopa is 600 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Patients experiencing dystonia:",
"     </i>",
"     Dosage reduction is recommended",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Brief interruption of therapy:",
"     </i>",
"     Reinitiate therapy at previous dose when patient is able to resume treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Extended interruption of therapy:",
"     </i>",
"     Reinitiate therapy at a lower dose and adjust gradually when patient is able to resume treatment",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2564095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13301007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments provided in manufacturer's labeling. Use in decompensated renal disease is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13301006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments provided in manufacturer's labeling. Use in decompensated hepatic disease is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F5950025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prolopa&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     50-12.5: Levodopa 50 mg and benserazide 12.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     100-25: Levodopa 100 mg and benserazide 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     200-50: Levodopa 200 mg and benserazide 50 mg",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11217268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F139697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with or immediately after meals. Capsules should be swallowed whole; do not crush, chew, open, or dissolve in liquid.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F139696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of Parkinson's disease (except drug-induced Parkinsonism)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F139726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmias, chest pain, edema, ECG changes (nonspecific), flushing, hypertension, orthostatic hypotension, pallor, phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety, ataxia, bruxism, confusion, delusions, dementia, depression, euphoria, faintness, fatigue, fever, gait abnormalities, hallucinations (mostly visual), headache, impulse control symptoms (including pathological gambling), insomnia, lethargy, malaise, neuroleptic malignant-like syndrome, nightmares, oculogyric crisis, on-off phenomena, paranoid ideation, psychotic episodes, sedation, seizures, somnolence, suicidal tendencies/behavior, temporal disorientation, trismus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatological: Alopecia, pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Libido increased, protein-bound iodine increased, uric acid increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distress or pain, anorexia, burning sensation on tongue, constipation, diarrhea, duodenal ulcer, dysphagia, epigastric pain, eructation, flatulence, GI bleeding, nausea, sialorrhea, taste alterations, vomiting, weight gain/loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Discoloration of urine, hematuria, nocturia, urinary frequency, urinary retention or incontinence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, hemolytic anemia (rare), leukopenia (transient), Positive Coombs' test, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, bilirubin increased, LDH increased, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Akinesia paradoxica, choreiform and involuntary movements, dystonia, end-of-dose akinesia, hand tremor, low back pain, muscle spasm and twitching, musculoskeletal pain, numbness, torticollis, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Activation of latent Horner's syndrome, blepharospasm, blurred vision, diplopia, diluted pupils",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bizarre breathing pattern, cough, hoarseness, postnasal drip",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, discoloration of sweat, hiccups, hypersensitivity reactions,  lip/mouth/tongue tightness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F139700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to benserazide, levodopa, sympathomimetics, or any component of the formulation; use with or within 14 days of MAO inhibitors; patients with clinical laboratory evidence of uncompensated cardiovascular, endocrine, renal, hepatic, hematologic, or pulmonary disease; patients with decompensated endocrine, renal, hepatic, cardiac disorders, psychiatric disorders, narrow-angle glaucoma, or closed-angle glaucoma; patients &lt;25 years of age (due to possibility of skeletal abnormalities from benserazide); pregnancy or use in women of childbearing potential without adequate contraception",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F139683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects:",
"     <b>",
"      [Canadian Boxed Warning]:",
"     </b>",
"     Patients have reported falling asleep while engaging in activities of daily living and sometimes without significant warning signs. Monitor for daytime somnolence or pre-existing sleep disorder; discontinue if significant daytime sleepiness or episodes of falling asleep occur. Patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Use with caution in patients receiving other CNS depressants or psychoactive agents. Effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Impulse control disorders: Dopamine agonists used for Parkinson&rsquo;s disease or restless legs syndrome have been associated with compulsive behaviors and/or loss of impulse control, which has manifested as pathological gambling, libido increases (hypersexuality), and/or binge eating. Causality has not been established, and controversy exists as to whether this phenomenon is related to the underlying disease, prior behaviors/addictions and/or drug therapy. Dose reduction or discontinuation of therapy has been reported to reverse these behaviors in some, but not all cases.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased growth hormone levels: May increase human growth hormone levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Melanoma: Risk for melanoma development is increased in Parkinson&rsquo;s disease patients; drug causation or factors contributing to risk have not been established. Patients should be monitored closely and periodic skin examinations should be performed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (MI, atrial, nodal, or ventricular arrhythmias); initiate in a monitored setting.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; antidiabetic agents may require dose adjustment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with chronic wide-angle glaucoma; monitor IOP carefully in patients with wide-angle glaucoma. Contraindicated in patients with narrow-angle and closed-angle glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment;. contraindicated in decompensated hepatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peptic ulcer disease: Use with caution in patients with peptic ulcer disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychotic disorders: Use with extreme caution in patients with psychotic disorders; observe patients closely for development of depression with concomitant suicidal tendencies.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment;. contraindicated in decompensated renal disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Current levodopa therapy: If patient is already receiving levodopa, discontinue levodopa at least 12 hours before starting levodopa/benserazide and begin at 15% of previous amount of levodopa.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenothiazines: Use with caution in patients receiving phenothiazines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tricyclic antidepressants (TCAs): Use with caution in patients receiving TCAs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to CNS effects of levodopa.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Not indicated in management of intention tremor, Huntington's chorea, or drug-induced extrapyramidal symptoms. Administer in careful increments and observe closely for development of abnormal involuntary movements.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dietary protein: Distribute dietary protein throughout the day to avoid fluctuations in levodopa absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Discontinuation of therapy: Dopaminergic agents have been associated with a syndrome resembling neuroleptic malignant syndrome (NMS) on abrupt withdrawal or significant dosage reduction after long-term use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Patient information: Patient must be instructed to resume normal activities gradually (rapid mobilization may increase risk of injury).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F139687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics (Atypical): May diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Consider using an alternative antipsychotic agent when possible in patients with Parkinson's disease.  If an atypical antipsychotic is necessary, consider using clozapine or quetiapine, which may convey the lowest interaction risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics (Typical): Anti-Parkinson's Agents (Dopamine Agonist) may diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist).  Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May diminish the therapeutic effect of Levodopa.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glycopyrrolate: May decrease the serum concentration of Levodopa.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the serum concentration of Levodopa. Only applies to oral iron preparations. Management: Consider separating doses of the agents by 2 or more hours to minimize the effects of this interaction. Monitor for decreased therapeutic effects of levodopa during concomitant therapy, particularly if doses cannot be separated.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: Levodopa may enhance the adverse/toxic effect of MAO Inhibitors. Of particular concern is the development of hypertensive reactions when levodopa is used with nonselective MAOI.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methionine: May diminish the therapeutic effect of Levodopa. Probably only with large doses of methionine.  Data was generated using 4.5gm daily.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May enhance the adverse/toxic effect of Anti-Parkinson's Agents (Dopamine Agonist).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May diminish the therapeutic effect of Levodopa. Multivitamins/Minerals (with ADEK, Folate, Iron) may decrease the serum concentration of Levodopa. Only applies to oral iron-containing preparations. Management: Separate doses of these agents by 2 or more hours.  Monitor for decreased levodopa effects, particularly if doses cannot be separated.  Concurrent use of a multivitamin and levodopa (without carbidopa) should be avoided.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May diminish the therapeutic effect of Levodopa.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyridoxine: May diminish the therapeutic effect of Levodopa. Management: The concomitant use of pyridoxine and levodopa (in the absence of a dopa decarboxylase inhibitor (DDI)) should be avoided. Use of a DDI (e.g., carbidopa) with levodopa will essentially eliminate the risk of this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sapropterin: May enhance the adverse/toxic effect of Levodopa.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F139713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: High-protein diets may decrease effect of levodopa; food impairs or reduces the rate and extent of levodopa absorption (15% to 30%). Iron salts (ferrous sulfate) may decrease the absorption of levodopa.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F139703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have been observed with levodopa in animal reproduction studies; use is contraindicated in pregnant women and women of childbearing age without proper contraception.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F139724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F139704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Breast-feeding is not recommended since occurrence of skeletal malformations in infants cannot be excluded.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F139705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     High-protein diets may decrease effect of levodopa.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F139692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Regular assessment of cardiovascular, hepatic, hematopoietic, and renal function; monitor blood glucose in patients with diabetes; symptoms of psychosis and dystonia",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F139706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Levazide (ID);",
"     </li>",
"     <li>",
"      Levoben (ID);",
"     </li>",
"     <li>",
"      Levopar (DE, ID);",
"     </li>",
"     <li>",
"      Levopar Plus (IL);",
"     </li>",
"     <li>",
"      Madopar (AR, AT, AU, CH, CL, CO, CZ, DE, DK, EE, ES, FI, GB, GR, HK, HN, ID, IE, IT, KP, MX, MY, NL, NO, NZ, PE, PH, PK, PL, PT, RU, SG, TH, TR, TW, VE);",
"     </li>",
"     <li>",
"      Madopar-F (IN);",
"     </li>",
"     <li>",
"      Madopark (SE);",
"     </li>",
"     <li>",
"      Modopar (FR);",
"     </li>",
"     <li>",
"      Prolopa (BE, BR, CN, PY, UY);",
"     </li>",
"     <li>",
"      Seler (PY);",
"     </li>",
"     <li>",
"      Tonotil (UY);",
"     </li>",
"     <li>",
"      Vopar (HK, TH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F139682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptoms of Parkinson&rsquo;s disease are due to a lack of striatal dopamine. Levodopa crosses into the blood-brain barrier (BBB) and is converted to dopamine by striatal enzymes. Benserazide inhibits the peripheral plasma breakdown of levodopa by inhibiting its decarboxylation and therefore increases levodopa availability at the BBB.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F139699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Benserazide: 66% to 74% from GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Benserazide: Does not cross the blood-brain barrier; mainly concentrated in kidneys, liver, lungs, and small intestine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Levodopa: 57 L; crosses the blood-brain barrier and not bound to plasma proteins",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Benserazide: Hydroxylated to trihydroxybenzylhydrazine, a potent inhibitor of decarboxylase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Levodopa: Major pathways: Decarboxylation and O-methylation; Minor pathways; Transamination and oxidation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Levodopa: 98% (range: 74% to 112%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Levodopa: 1.5 hours; 3-O-methyldopa (major metabolite): 15 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Benserazide: Urine (64%); feces (24%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Molina JA, S&agrave;inz-Artiga MJ, Fraile A, et al, &ldquo;Pathologic Gambling in Parkinson's Disease: A Behavioral Manifestation of Pharmacologic Treatment,&rdquo;",
"      <i>",
"       Mov Disord",
"      </i>",
"      , 2000, 15(5):869-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/30/486/abstract-text/11009192/pubmed\" id=\"11009192\" target=\"_blank\">",
"        11009192",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9796 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-29E1B55F6D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_486=[""].join("\n");
var outline_f0_30_486=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139718\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139728\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139721\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2564095\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13301007\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13301006\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5950025\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217268\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139697\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139696\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139726\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139700\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139683\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298828\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139687\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139713\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139703\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139724\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139704\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139705\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139692\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139706\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139682\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139699\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9796\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9796|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/17/18709?source=related_link\">",
"      Levodopa-benserazide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_487="Rapid expansion of abdominal aortic aneurysm on ultrasound";
var content_f0_30_487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 597px\">",
"   <div class=\"ttl\">",
"    Rapid expansion of abdominal aortic aneurysm on ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 577px; height: 502px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ultrasound images were performed six months apart and show rapid (&gt;0.5 cm)&nbsp;expansion of an abdominal aortic aneurysm (AAA) (A to B)&nbsp;and advancing hydronephrosis (white arrow) (C to D).&nbsp;Perianeurysmal fibrosis with secondary progressive ureteral obstruction, as would be seen with an inflammatory aneurysm,&nbsp;could explain these findings.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_487=[""].join("\n");
var outline_f0_30_487=null;
var title_f0_30_488="Folliculitis in dark skin";
var content_f0_30_488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small inflammatory papules and pustules are present in this patient with folliculitis. Erythema is difficult to appreciate due to dark skin pigmentation. Postinflammatory hyperpigmentation is also present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_488=[""].join("\n");
var outline_f0_30_488=null;
var title_f0_30_489="Principles of infection control in long-term care facilities";
var content_f0_30_489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of infection control in long-term care facilities",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/489/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/489/contributors\">",
"     Michael J Richards, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/489/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/489/contributors\">",
"     Anthony Harris, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/489/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/489/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/30/489/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rather than being just \"old folks homes,\" long-term care facilities (LTCFs) represent a complex group of ever-evolving health care systems that serve persons from all age groups and provide variable levels of care to individuals unable to care for themselves. This diverse group of facilities includes skilled-nursing facilities providing post-acute care, nursing homes, assisted living facilities, retirement homes, rehabilitation centers, long-term care hospitals, long-term psychiatric facilities, and institutions for those with intellectual disabilities.",
"   </p>",
"   <p>",
"    These facilities provide a unique environment favoring the transmission of infections to residents. Infection control practices should allow for the fact that these facilities are a home for many residents as well as a place of nursing, medical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    psychosocial care for their residents. Facilities differ considerably, and an effective infection control program should be designed around the specific needs and risks of the residents as well as available resources.",
"   </p>",
"   <p>",
"    The general issues involved in infection control in LTCFs will be reviewed here, emphasizing the more important and topical areas of this expanding field. Such infections are a form of non-nosocomial (outpatient) healthcare associated infections as opposed to hospital-acquired (nosocomial) healthcare associated infections.",
"   </p>",
"   <p>",
"    Specific sites and pathogens responsible for infections in these facilities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/34/26152?source=see_link\">",
"     \"Important sites and pathogens causing infections in long-term care facilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the population ages and technology improves to care for patients with previously fatal conditions, both the number and proportion of persons in LTCFs will increase. Approximately 2.5 million Americans now live in these facilities. Five percent of Americans over the age of 65 currently reside in nursing homes, and up to 43 percent of those turning 65 in the United States will be admitted to a nursing home before they die. In Norway, there were twice as many long-term care beds in 2000 as compared to 1984 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/1\">",
"     1",
"    </a>",
"    ]. Changes in acute care practices are moving more acutely ill persons from hospitals into LTCFs, resulting in changes in both the composition and number of persons in LTCFs. Residents of LTCFs may now occasionally have central venous lines and even require mechanical ventilation.",
"   </p>",
"   <p>",
"    The incidence of nosocomial infections in LTCFs is comparable to that in acute care hospitals in both total number and rate of infections [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/2\">",
"     2",
"    </a>",
"    ]. The incidence of nosocomial infections ranges from 2.6 to 14 infections per 1000 resident-days [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Infections contribute to 63 percent of deaths in LTCFs and are the primary reason for 25 to 50 percent of transfers to acute care hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/4\">",
"     4",
"    </a>",
"    ]. Residents average at least one serious infection per year. Infections may be sporadic, endemic or epidemic and transmitted in a variety of ways.",
"   </p>",
"   <p>",
"    Residents of these institutions are subject to infections circulating in the community, those normally considered to be healthcare-associated, and those unique to persons with a wide range of disabilities (",
"    <a class=\"graphic graphic_table graphicRef62996 \" href=\"UTD.htm?22/21/22875\">",
"     table 1",
"    </a>",
"    ). Infection is facilitated by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immunosenescence",
"     </li>",
"     <li>",
"      Underlying chronic medical illnesses",
"     </li>",
"     <li>",
"      Fecal and urinary incontinence",
"     </li>",
"     <li>",
"      Depressed mental state",
"     </li>",
"     <li>",
"      Protracted use of devices such as urinary catheters and nasogastric tubes",
"     </li>",
"     <li>",
"      Medications that suppress the immune system or the central nervous system",
"     </li>",
"     <li>",
"      Advanced age",
"     </li>",
"     <li>",
"      Factors that promote person-to-person transmission such as crowding and sharing of meals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Antibiotic-resistant bacteria are frequently present in LTCFs, and 25 to 75 percent of antibiotic use may be inappropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/5\">",
"     5",
"    </a>",
"    ]. Antibiotic-resistant organisms can be easily transferred between LTCFs and acute care hospitals and vice versa because patients typically move back and forth between the two facilities. LTCFs often lack adequate infection control programs and sufficient space for handwashing and isolation of patients.",
"   </p>",
"   <p>",
"    Infection control in these settings is a fascinating mix of hospital and community public health. The Association for Practitioners in Infection Control (APIC) has developed guidelines for infection prevention and control in LTCFs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/6\">",
"     6",
"    </a>",
"    ], which are among the most complete recommendations to date.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HISTORY OF INFECTION CONTROL PROGRAMS IN LTCFS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of past problems with infection control programs in LTCFs have been improved through regulations, studies, and concerted efforts on the part of the facilities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Past deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in the United States in the 1980s indicated major deficiencies in infection control practices and programs in LTCFs, but also growing interest in this area [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. A picture emerged of institutions with high patient-staff ratios, considerable non-professional staffing with high turnover, and few infection control policies. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 53 Maryland nursing homes, more than half had insufficient or no isolation policies for infected decubitus ulcers or acute diarrhea, although employee health issues were more adequately addressed [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a North Carolina study of 12 facilities in 1985, none of the Infection Control Practitioners (ICPs) had attended an infection control education course, and the ICP spent an average of only two hours per week on infection control [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many LTCFs failed to perform systematic surveillance, lacked isolation facilities, had a shortage of sinks, and had deficiencies in employee and resident health care programs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     The present",
"    </span>",
"    &nbsp;&mdash;&nbsp;The present situation appears to be improving [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/10\">",
"     10",
"    </a>",
"    ]. Training opportunities for LTCF ICPs are being developed. A two-day training in basic skills developed in Nebraska has been evaluated and shown to be effective in producing improvements in knowledge and implementation of recommended infection control practices in LTCFs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/11\">",
"     11",
"    </a>",
"    ]. A Connecticut study of skilled nursing facilities in 1990 showed almost all ICPs had received some training in IC, and had worked in the field for an average of 3.5 years. More than half had a link with hospital ICPs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a survey of northeastern United States LTCFs, 98 percent of facilities had ICPs spending a median of 8 hours per week on infection control activities. Fifty two percent of these personnel had formal training in infection control [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/3\">",
"     3",
"    </a>",
"    ]. In contrast, British nursing homes usually do not have a designated infection control nurse [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     REGULATORY REQUIREMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regulatory requirements add impetus to these changes. Skilled nursing facilities are required by the OBRA act of 1987 to have an infection control program. LTCFs must comply with OSHA guidelines, particularly aimed at prevention of transmission of blood borne pathogens to healthcare workers. Facilities participating in Medicare and Medicaid programs are required by the HCFA Centers for Medicare and Medicaid Services (CMS) to establish policy and procedures to investigate infections in the facility. Requirements of the program have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Veterans Affairs Nursing Homes must be accredited by the Joint Commission of Healthcare Organizations (JCAHO), which requires an effective facility wide program oversight, and written policies, procedures for surveillance, prevention, and control of infection for all patients and staff [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/15\">",
"     15",
"    </a>",
"    ]. In 1996 the JCAHO long-term care standards were issued requiring a coordinated infection control process [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/16\">",
"     16",
"    </a>",
"    ]. State requirements for LTCFs vary widely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     STRUCTURE OF AN INFECTION CONTROL PROGRAM",
"    </span>",
"    &nbsp;&mdash;&nbsp;A designated infection control practitioner (ICP) and an Infection Control Committee (ICC) are fundamental components of an infection control program. The program requires interdisciplinary cooperation, with contributions from the facility administration, medical director, the staff and the local health department. The APIC guidelines suggest for maximal efficiency that an ICC consist of the ICP, administrator and medical director [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/6\">",
"     6",
"    </a>",
"    ]. The ICC should oversee the infection control program. The functions of an infection control program are listed in Table 2 (",
"    <a class=\"graphic graphic_table graphicRef71795 \" href=\"UTD.htm?11/49/12060\">",
"     table 2",
"    </a>",
"    ). The Medical Director should review the program at least annually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infection control practitioner",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ICP is usually a registered nurse with other responsibilities. The requirements of the ICP include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific training in infection control",
"     </li>",
"     <li>",
"      Personal skills in interactions with hospital staff, medical personnel, residents, and their families",
"     </li>",
"     <li>",
"      Knowledge and experience in resident assessment and chart review",
"     </li>",
"     <li>",
"      Knowledge of geriatric infectious diseases and basic microbiologic culture techniques",
"     </li>",
"     <li>",
"      Educational skills, since education is vital, particularly for nursing aides who have frequent resident contacts",
"     </li>",
"     <li>",
"      Support from the administration for appropriate educational opportunities and resources including expert consultation in infectious diseases and infection control",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    How large an institution should be to justify a full-time ICP has not been investigated and will depend upon the nature of patients in the facility. Lack of time for the ICP to adequately fulfill infection control responsibilities was identified as a problem in early studies. An effective infection prevention program can provide the foundation for expanding performance improvement throughout the LTCF, where initiatives share similar methods and principles [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary and most significant use of surveillance data in LTCFs is in the detection of outbreaks, increases in infection rates, and problems requiring some type of specific infection control intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/19\">",
"     19",
"    </a>",
"    ]. Monitoring of disease patterns over time may provide information on the effectiveness of changes in infection control practices and policies. Surveillance may also indicate the need for additional training and staff education. In the United States, routine illness surveillance within a LTCF is required by HCFA [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surveillance systems should be relatively simple in order to be effective since the ICP usually has only a few hours per week for infection control activities. The basic components of a surveillance system include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A mechanism for data collection",
"     </li>",
"     <li>",
"      A schedule and procedure for routinely evaluating data and making comparisons",
"     </li>",
"     <li>",
"      A means for disseminating the results of those evaluations to those who have a need to know",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hospital designed surveillance techniques may be inappropriate and unworkable in LTCFs because available time, laboratory data, and medical records differ.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Data collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance definitions for infections among residents of LTCFs serving the elderly have been developed but have not been validated [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/19\">",
"     19",
"    </a>",
"    ]. Simple definitions of nosocomial infections are required. Several groups have recommended surveillance data collection through periodic rounds rather than chart reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/17\">",
"     17",
"    </a>",
"    ]. Conversations with unit nursing staff and residents, and clinical observations are important components of these rounds. Although data can be collected through periodic review of charts, laboratory reports and other records, the amount and quality of information is often considerably less than from these same sources in hospitals. The frequency of data collection depends upon how much new information is likely to be available. Weekly surveillance has been recommended as a minimum [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Infection rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Crude infection rates for different sites of infection may be calculated using the number of infections as the numerator and daily census as the denominator. These rates may help to identify outbreaks. However, these rates should not be used to compare one institution to another. To accomplish this latter goal, additional data must be collected to facilitate calculating infection rates with risk adjustment. While risk adjusted infection rates are the most accurate for interfacility comparisons, they are time consuming to perform.",
"   </p>",
"   <p>",
"    One method used for interfacility comparison of infection rates created a standardized regional data set to provide an external benchmark for interfacility comparisons [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/20\">",
"     20",
"    </a>",
"    ]. Infection rates in particular groups of residents (eg, patients with urinary catheters or other risk factors) may be more useful for comparisons with other units within the facility. It may be more useful to express these rates in terms of specific exposures (eg, catheter-days) rather than using an overall census denominator. With difficulty in determining infections in long-term care facilities, antibiotic use may be a useful surrogate measure. Studies using antibiotic use as a surrogate, demonstrate substantial interfacility variation although after adjusting for case mix, these rates are primarily driven by infection rates [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Data use, analysis and presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information can be organized into a line list (an ongoing list of individuals meeting surveillance criteria for suffering a nosocomial infection). Computerized spreadsheet programs can be very helpful in maintaining and organizing surveillance information. These should be augmented with a list of locally notifiable diseases and conditions, which can be obtained from state or local health departments.",
"   </p>",
"   <p>",
"    The frequency of evaluation depends upon the size of the facility. Larger facilities should examine data at least weekly, while smaller facilities can use a biweekly or monthly interval. The purpose of evaluation is to detect sentinel or trigger events; mechanisms for action and follow-up should be planned in advance. Examples of sentinel events might include the identification of a resident with scabies crustosa (Norwegian scabies) or detection of two cases of diarrheal illness among residents of the same unit within one week. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More subtle problems such as increases in respiratory or urinary tract infections (UTI) are best detected by comparisons with previous weeks. Information on trends should be provided back to units and employees.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Reporting of notifiable diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consideration should be given to state and local notifiable disease reporting. State and local health officers and licensing officials may be contacted for input in determining sentinel events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Outbreaks of infectious diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outbreaks may be broadly defined as an unusual increase in illness above baseline levels. In LTCFs, respiratory and gastrointestinal viral infections are relatively frequent and may attack a large proportion of the residents and healthcare workers. These outbreaks may range in severity from mild upper respiratory tract or diarrhea to life threatening dehydration or pneumonia. Although we often think of outbreaks in terms of several cases, in some instances, a single event may be sufficient to initiate a response. Examples of such situations include scabies, meningococcal meningitis to infections with certain antibiotic-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).",
"   </p>",
"   <p>",
"    A real function of surveillance is to promptly identify increases, so that control measures may be instituted in a timely fashion. The development of written procedures for managing outbreaks will contribute to timely interventions. Procedures should be developed for initial management of outbreaks involving common sites or pathogens. These may be determined on the basis of experience",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    consultation with local licensing and health officials. Issues that need to be considered in an outbreak management plan include those of screening, isolation, contact identification and prophylaxis. Provisions should be made for obtaining the necessary authorization for specimen collection and prophylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION PRACTICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;While a good surveillance program will identify problems and a well-designed management plan will help institute timely and effective control measures, it is those policies and procedures that are implemented on a daily basis that prevent problems in the first place.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Written procedures and guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Written procedures and guidelines should address topics such as immunizations, handwashing, changing catheters and dressings, management of spills of blood and body fluids, handling of linens, cleaning and disinfection. Staff training and monitoring is a key component to an effective infection control program. Training should be formal and informal, sufficiently frequent to address needs arising from staff turnover, and should be readily understandable by all employees. This may be especially difficult since turnover rates among nurses' aides, the major direct care givers, may range from 70 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/22\">",
"     22",
"    </a>",
"    ]. Orientation for aides should include assessment of residents for infections, handwashing, modes of transmission of infection, staff hygiene, and employee health. Mechanisms for monitoring and evaluating staff performance and for promoting infection control policies should be developed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Isolation precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;LTCFs often lack private rooms and rooms with appropriate ventilation for patient isolation. Contact precautions generally adopted in hospitals may be used with modification in LTCFs. These involve:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wearing gloves if making contact with mucous membranes or non intact skin",
"     </li>",
"     <li>",
"      Hand hygiene with soap and water or with alcohol based hand rubs",
"     </li>",
"     <li>",
"      Private rooms for residents where possible",
"     </li>",
"     <li>",
"      Barriers to protect healthcare workers from body substances",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some of these precautions may be difficult to implement in LTCFs. Guidelines for glove, mask and gown use have been developed by APIC [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/6\">",
"     6",
"    </a>",
"    ]. If adequate isolation facilities are not available, residents may need to be transferred to acute hospitals for some conditions, particularly tuberculosis and transmissible infections with antibiotic-resistant bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/23\">",
"     23",
"    </a>",
"    ]. Clear communication between the LTCF and the hospital at the time of transfer is essential, especially about potentially transmissible pathogens. Guidelines for disinfectants, patient care equipment, linen and transportation have been developed for patients with antibiotic-resistant organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hand hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hand hygiene is the",
"    <strong>",
"     single most important",
"    </strong>",
"    infection control measure. Non-medicated bar or liquid soaps are adequate. Alcohol-based hand hygiene product (eg, foams, gels, disposable towelettes, or soap substitutes) may be used if no visible soiling or debris are present on hands and especially during procedures with multiple patient contacts. Hand hygiene should be performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Before and after each contact with a resident",
"     </li>",
"     <li>",
"      After any contact with blood or body fluids",
"     </li>",
"     <li>",
"      After removing gloves",
"     </li>",
"     <li>",
"      After contact with surfaces or equipment that may be contaminated with antibiotic- resistant organisms",
"     </li>",
"     <li>",
"      After assisting with feeding",
"     </li>",
"     <li>",
"      After leaving an isolation room",
"     </li>",
"     <li>",
"      After handling dressings, bedpans, catheters or urinals",
"     </li>",
"     <li>",
"      After prolonged contact with dry and intact skin",
"     </li>",
"     <li>",
"      After personal use of the toilet",
"     </li>",
"     <li>",
"      After blowing or wiping the nose",
"     </li>",
"     <li>",
"      Upon completion of duty",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Visitors should be instructed to wash their hands before and after contact with a resident, after contact with body fluids, and before and after feeding residents.",
"   </p>",
"   <p>",
"    Handwashing is recommended for procedures such as insertion of an intravenous line or a urinary catheter. Major deficiencies in handwashing persist. As an example, use of gloves and adherence to handwashing guidelines were examined in one study of 230 staff-resident contacts in a 255 bed LTCF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/9\">",
"     9",
"    </a>",
"    ]. Handwashing occurred 63 percent of the time after but only 27 percent before and 0 percent during a contact with a patient. It was estimated from this study that transmission of an organism was possible in 158 of 193 (82 percent) evaluable interactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Sharp injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Practices for avoiding sharp injuries and the disposal of sharps in LTCFs should be similar to those used in acute care facilities. Needlestick injuries occur in nursing homes and are often related to needle recapping [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/24\">",
"     24",
"    </a>",
"    ]. Needles should not be manually recapped. In the 1990s increasing numbers of patients with human immunodeficiency virus (HIV) infection have been cared for in LTCFs. An outbreak of hepatitis B was reported related to sharps from reusable fingerstick blood sampling instruments in LTCFs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/25\">",
"     25",
"    </a>",
"    ]. A protocol should be developed with arrangements for urgent access to expert help and appropriate medication after needlestick accidents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are used extensively in LTCFs. The probability of receiving at least one course of systemic antibiotics during a one year period is greater than 50 percent for a resident of an LTCF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Antibiotics are frequently given for protracted periods and for inappropriate indications, particularly for urinary tract colonization associated with catheter use and for pressure sores that are not infected. Antibiotics are often prescribed over the telephone. Some studies report that 25 to 75 percent of systemic antimicrobials were prescribed inappropriately [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnosis of infection can be difficult in the elderly. Symptoms can be nonspecific, and laboratory and radiology support limited. Many patients with pneumonia do not have a chest radiograph taken. Asymptomatic bacteriuria is common in the elderly, and a positive urine culture is thus not strongly predictive of urinary tract infection as the cause of fever in the setting. The Society for Hospital Epidemiology of America (SHEA) has developed a position paper to address the need to promote optimal antibiotic use in LTCFs, including recommendations for empiric therapy and an approach to the management of upper respiratory, lower respiratory, skin and soft tissue infections, diarrhea, and fever of unknown origin [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further recommendations involve reporting, educational and other approaches used in acute care facilities such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Review of antimicrobial utilization in the infection control program using a multidisciplinary approach, involving physicians, pharmacists, nursing staff, the medical director, as well as the ICP",
"     </li>",
"     <li>",
"      Monitoring antibiotic dosage, duration, and costs, and reviewing data on a regular basis",
"     </li>",
"     <li>",
"      Developing and promoting programs for judicious antibiotic use",
"     </li>",
"     <li>",
"      Consideration of using antibiotic order forms, automatic stop orders, and limited susceptibility reporting",
"     </li>",
"     <li>",
"      Developing guidelines for the use of antimicrobial agents in patients in whom \"comfort measures only\" are being provided",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In selected facilities, more intensive programs should be undertaken, including assessment of antibiotic appropriateness, and plans for response if high levels of inappropriate use are identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Antibiotic resistant bacteria in LTCFs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergence of antibiotic resistant bacteria in LTCFs is a concern to health care providers, public health officials, and facility administrators [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. An extraordinarily high incidence of antimicrobial resistant isolates has been reported from some LTCFs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/35\">",
"     35",
"    </a>",
"    ]. This incidence varies widely. Rapid dissemination of antimicrobial resistant strains of bacteria may occur, and once established, these bacteria may persist in these institutions. Contributing factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two-way traffic of residents and patients between LTCFs and hospitals, transferring antibiotic resistant bacteria with the patients. One study of VRE colonization in a regional health system including acute care facilities and LTCFs reported that the incidence was higher in the acute care facilities (7 versus 2 percent), but colonized LTCF patients were significantly more likely than non-colonized residents to have been hospitalized at one of the acute care facilities (63 versus 18 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/36\">",
"       36",
"      </a>",
"      ]. The LTCFs may be seen as \"amplifiers and reservoirs\" of antibiotic resistant bacteria by the hospitals, leading to concern by the acute care facilities when patients are transferred.",
"     </li>",
"     <li>",
"      Selection and mutation of antibiotic resistant bacteria in the facility. In one study, after 70 percent of 63 courses of antibiotics for UTI in patients with indwelling catheters, bacteriuria developed that was resistant to the initial antibiotic [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Plasmid transfer between species and genus of bacteria has been documented in nursing home outbreaks.",
"     </li>",
"     <li>",
"      High rates of person-to-person transmission, facilitated by community activities with direct contacts between residents or via staff with inadequate training or handwashing. In a study of 50 nursing homes in Canada and the United States, increased staffing, more sinks, and use of antimicrobial soap was associated with reduced antimicrobial resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Long-term use of urinary catheters and other invasive devices or foreign bodies [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/39\">",
"       39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Outbreaks of resistant organisms in long-term care facilities",
"     </li>",
"     <li>",
"      Higher rates of antibiotic resistant S. pneumoniae in long-term care residents than in the community [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Resistant organisms in the facility may directly cause increased morbidity and also lead to greater antibiotic expenditures because of the need to move to more expensive antimicrobial agents. Isolation procedures can also increase costs (gloves, gowns, single rooms), and may considerably limit the mobility and socialization of residents. The LTCF should have a policy dealing with resistant bacteria such as MRSA and VRE. The recommendations of the Society for Hospital Epidemiology of America (SHEA) are listed in Table 1 (",
"    <a class=\"graphic graphic_table graphicRef70780 \" href=\"UTD.htm?27/41/28315\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For LTCFs with a low rate of endemic infections caused by antimicrobial resistant pathogens (less than one case per 1000 resident days), additional control measures recommended include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monthly analysis of surveillance data to identify cross infection or colonization",
"     </li>",
"     <li>",
"      Residents with resistant organisms should not be placed in rooms with debilitated, non-ambulatory residents at greatest risk of becoming colonized or infected",
"     </li>",
"     <li>",
"      Single rooms or cohorting strategies should be used judiciously to minimize dissemination of resistant organisms into the environment from residents shedding large numbers of bacteria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, for LTCFs with high rates of endemic infection (&gt;1 case per 1000 resident days) or an outbreak, consultation with an experienced epidemiologist is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     HEALTH POLICIES FOR RESIDENTS AND EMPLOYEES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The APIC guidelines suggest that resident and employee health programs be part of infection control activities in LTCF facilities. Issues for the residents such as immunization, prevention of aspiration, skin care, tuberculosis screening and UTIs should be included in these programs. These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/34/26152?source=see_link\">",
"     \"Important sites and pathogens causing infections in long-term care facilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Immunizations for residents",
"    </span>",
"    &nbsp;&mdash;&nbsp;An aggressive approach to immunization should be part of every infection control program in LTCFs. The use of standing orders for vaccination of LTCF residents is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/41\">",
"     41",
"    </a>",
"    ]. The three most important vaccines for elderly residents of these facilities are influenza vaccine, pneumococcal vaccine and tetanus-diphtheria toxoids [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Influenza vaccine is effective in elderly persons and should be given annually in the autumn. However, influenza outbreaks can occur in long-term care facilities even when &ge;80 percent of residents are vaccinated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link&amp;anchor=H14#H14\">",
"       \"Seasonal influenza vaccination in adults\", section on 'Elderly patients'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumococcal vaccine should be given at age 65 or on admission to the LTCF if the patient is over 65 years, unless the resident has been recently immunized. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"       \"Pneumococcal vaccination in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recommendations for tuberculosis are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/34/26152?source=see_link\">",
"       \"Important sites and pathogens causing infections in long-term care facilities\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tetanus and diphtheria vaccine should be offered every ten years. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link\">",
"       \"Tetanus-diphtheria toxoid vaccination in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Employee health policies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Employees in LTCFs are less likely than health care workers in acute care facilities to have formal education or previous professional experience in healthcare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;All employees should have an initial assessment of their medical history, health status, and immunizations. A history of past varicella, measles, hepatitis, and recurrent skin infections should be sought.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Vaccinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccination against influenza and hepatitis B should be offered to those who are not immune. The efficacy of this approach was illustrated in three randomized trials in the United Kingdom in which health care workers were offered influenza vaccination at intervention LTCFs, and were not offered vaccination at control sites [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. Employee vaccination rates in the intervention facilities ranged from 48 to 61 percent. During years of influenza activity, the mortality rates for patients in the institutions in which influenza vaccine was administered were significantly lower in all three studies: 13.6 versus 22.4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/43\">",
"     43",
"    </a>",
"    ]; 10 versus 17 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/44\">",
"     44",
"    </a>",
"    ]; and 11.2 versus 15.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Influenza-like illness in intervention sites was lower in two studies [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/44,45\">",
"     44,45",
"    </a>",
"    ], although the incidence of influenza infection as determined by virologic surveillance among residents did not differ in the third [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/43\">",
"     43",
"    </a>",
"    ]. Thus, immunizing even one-half of the health care worker population reduces mortality and influenza illness in residents of LTCFs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risks of transmission of tuberculosis in these institutions should be explained. A program should be instituted for preemployment Mantoux testing, chest radiographs for unexplained positive reactors, and annual testing of nonreactors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Blood borne infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveys suggest that in the past personnel in LTCFs may have been relatively uninformed about transmission of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/46\">",
"     46",
"    </a>",
"    ]. Education on precautions to reduce the risk of transmission of blood borne pathogens, including disposal of sharps (see above), and body substance isolation should be offered to all employees with contact with residents. There should be an established rapid mechanism for access to appropriate post exposure prophylaxis if the staff have an incident of potential HIV or hepatitis B or C exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/489/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Hand hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instruction in the method and role of hand hygiene in the prevention of disease transmission should be given (see above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Reporting of ill health",
"    </span>",
"    &nbsp;&mdash;&nbsp;Employees should report significant communicable diseases, and cough, rash or diarrhea. They should not have contact with residents or their food while potentially infectious.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     THE FUTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The awareness of the risks of nosocomial infections to LTCF residents, concerns over the potential risks to a wider community from antibiotic-resistant pathogens that may be amplified in nursing homes, increasing community expectations for quality assessment, new research findings, and improvements in information technology that will make data collection and analysis more accessible, should accelerate improvements in infection control practices in LTCFs. Financial restraints, particularly as a larger proportion of the population use these facilities, may retard this progress, since basic engineering needs for sinks and single rooms, and increased educational requirements and skills for staff will add to the costs of care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23872926\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The encompassing term &ldquo;long-term care facility&rdquo; (LTCF) includes skilled-nursing facilities providing post-acute care, nursing homes, assisted living facilities, retirement homes, rehabilitation centers, long-term care hospitals, long-term psychiatric facilities, and institutions for those with intellectual disabilities. Residents of these institutions are subject to infections circulating in the community, those normally considered to be healthcare-associated, and those unique to persons with a wide range of disabilities (",
"      <a class=\"graphic graphic_table graphicRef62996 \" href=\"UTD.htm?22/21/22875\">",
"       table 1",
"      </a>",
"      ). LTCF often lack adequate infection prevention and control programs, and have high rates of inappropriate antibiotic use, but the situation is improving. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A designated infection control practitioner (ICP) and Infection Control Committee (ICC) are fundamental components of an infection control program. The major functions of such programs include the following (",
"      <a class=\"graphic graphic_table graphicRef71795 \" href=\"UTD.htm?11/49/12060\">",
"       table 2",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Surveillance of prespecified infections to aid in the detection of outbreaks, increases in infection rates, and problems that may require a specific infection control intervention. The surveillance program should be relatively simple, as resources are usually quite limited. Certain infections may need to be reported to public health or governmental infection control agencies. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Surveillance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Establishment and enforcing of policies to prevent the acquisition and spread of infections, including isolation precautions, hand hygiene policies, and practices to avoid sharps injuries. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prevention practices'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Review of antimicrobial utilization and development of programs for judicious antibiotic use. This is particularly important to curb the emergence of antibiotic resistant bacteria in LTCFs. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Antibiotic use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Institution of health policies for residents and employees, such as immunization against vaccine preventable diseases, to reduce the risk of infection. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Health policies for residents and employees'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/1\">",
"      Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. J Hosp Infect 2004; 57:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/2\">",
"      Smith PW, Daly PB, Roccaforte JS. Current status of nosocomial infection control in extended care facilities. Am J Med 1991; 91:281S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/3\">",
"      Goldrick BA. Infection control programs in skilled nursing long-term care facilities: an assessment, 1995. Am J Infect Control 1999; 27:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/4\">",
"      Smith PW. Infection control in the long-term healthcare facility. Geriatrics 1989; 44 Suppl A:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/5\">",
"      Nicolle LE, Bentley DW, Garibaldi R, et al. Antimicrobial use in long-term-care facilities. SHEA Long-Term-Care Committee. Infect Control Hosp Epidemiol 2000; 21:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/6\">",
"      Smith PW, Rusnak PG. APIC guideline for infection prevention and control in the long-term care facility. Am J Infect Control 1991; 19:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/7\">",
"      Garibaldi RA, Brodine S, Matsumiya S. Infections among patients in nursing homes: policies, prevalence, problems. N Engl J Med 1981; 305:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/8\">",
"      Khabbaz RF, Tenney JH. Infection control in Maryland nursing homes. Infect Control Hosp Epidemiol 1988; 9:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/9\">",
"      Thompson BL, Dwyer DM, Ussery XT, et al. Handwashing and glove use in a long-term-care facility. Infect Control Hosp Epidemiol 1997; 18:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/10\">",
"      Pearson DA, Checko PJ, Hierholzer WJ Jr, Jekel JF. Infection control practices in Connecticut's skilled nursing facilities. Am J Infect Control 1990; 18:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/11\">",
"      Daly PB, Smith PW, Rusnak PG, et al. Impact on knowledge and practice of a multiregional long-term care facility infection control training program. Am J Infect Control 1992; 20:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/12\">",
"      Pearson DA, Checko PJ, Hierholzer WJ Jr, Jekel JF. Infection control practitioners and committees in skilled nursing facilities in Connecticut. Am J Infect Control 1990; 18:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/13\">",
"      Mayon-White R, Grant-Casey J. Infection control in British nursing homes. Infect Control Hosp Epidemiol 2003; 24:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/14\">",
"      Medicare and Medicaid; requirements for long term care facilities--HCFA. Final rule. Fed Regist 1991; 56:48826.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cms.gov/NHCompare.",
"    </li>",
"    <li>",
"     The Joint Commission on Accreditation of Healthcare Organizations. Comprehensive Accreditation Manual for Long Term Care. The Joint Commission on Accreditation of Healthcare Organizations, Chicago, 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/17\">",
"      Smith PW. Consensus conference on nosocomial infections in long-term care facilities. Am J Infect Control 1987; 15:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/18\">",
"      Stevenson KB, Loeb M. Performance improvement in the long-term-care setting: building on the foundation of infection control. Infect Control Hosp Epidemiol 2004; 25:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/19\">",
"      McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/20\">",
"      Stevenson KB. Regional data set of infection rates for long-term care facilities: description of a valuable benchmarking tool. Am J Infect Control 1999; 27:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/21\">",
"      Mylotte JM. Antimicrobial prescribing in long-term care facilities: prospective evaluation of potential antimicrobial use and cost indicators. Am J Infect Control 1999; 27:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/22\">",
"      Libow LS, Starer P. Care of the nursing home patient. N Engl J Med 1989; 321:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/23\">",
"      Cahill CK, Rosenberg J. Guideline for prevention and control of antibiotic-resistant microorganisms in california long-term care facilities. Centers for Disease Control. J Gerontol Nurs 1996; 22:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/24\">",
"      Crossley K, Willenbring K, Thurn J. Needlestick injuries and needle disposal in Minnesota nursing homes. J Am Geriatr Soc 1990; 38:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/25\">",
"      Centers for Disease Control and Prevention (CDC). Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices--Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/26\">",
"      Montgomery P, Semenchuk M, Nicolle LE. Antimicrobial use in nursing homes in Manitoba. J Geriatric Drug Therapy 1995; 9:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/27\">",
"      Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc 1991; 39:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/28\">",
"      Jones SR, Parker DF, Liebow ES, et al. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med 1987; 83:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/29\">",
"      Katz PR, Beam TR Jr, Brand F, Boyce K. Antibiotic use in the nursing home. Physician practice patterns. Arch Intern Med 1990; 150:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/30\">",
"      Nicolle LE, Bentley D, Garibaldi R, et al. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996; 17:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/31\">",
"      Loeb M, Bentley DW, Bradley S, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol 2001; 22:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/32\">",
"      Bentley DW, Bradley S, High K, et al. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin Infect Dis 2000; 31:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/33\">",
"      Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996; 17:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/34\">",
"      Bonomo RA, Rice LB. Emerging issues in antibiotic resistant infections in long-term care facilities. J Gerontol A Biol Sci Med Sci 1999; 54:B260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/35\">",
"      Flournoy DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology 1994; 40:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/36\">",
"      Trick WE, Kuehnert MJ, Quirk SB, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999; 180:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/37\">",
"      Bjork DT, Pelletier LL, Tight RR. Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients. Infect Control 1984; 5:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/38\">",
"      Loeb MB, Craven S, McGeer AJ, et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003; 157:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/39\">",
"      Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 34:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/40\">",
"      Kupronis BA, Richards CL, Whitney CG, Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003; 51:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/41\">",
"      McKibben LJ, Stange PV, Sneller VP, et al. Use of standing orders programs to increase adult vaccination rates. MMWR Recomm Rep 2000; 49:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/42\">",
"      Schneider EL. Infectious diseases in the elderly. Ann Intern Med 1983; 98:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/43\">",
"      Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/44\">",
"      Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/45\">",
"      Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006; 333:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/46\">",
"      Prather MC, Hoff GL, Biery RM, Bayer WL. Patient with AIDS in nursing home. Am J Infect Control 1987; 15:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/489/abstract/47\">",
"      Gropper EI. Can your nursing home resident possibly have AIDS? Geriatr Nurs 1990; 11:240.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3807 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-81EFD22CC2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_489=[""].join("\n");
var outline_f0_30_489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23872926\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HISTORY OF INFECTION CONTROL PROGRAMS IN LTCFS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Past deficiencies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      The present",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      REGULATORY REQUIREMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      STRUCTURE OF AN INFECTION CONTROL PROGRAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infection control practitioner",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Data collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Infection rates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Data use, analysis and presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Reporting of notifiable diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Outbreaks of infectious diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION PRACTICES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Written procedures and guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Isolation precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hand hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Sharp injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ANTIBIOTIC USE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Antibiotic resistant bacteria in LTCFs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      HEALTH POLICIES FOR RESIDENTS AND EMPLOYEES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Immunizations for residents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Employee health policies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Vaccinations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Blood borne infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Hand hygiene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Reporting of ill health",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      THE FUTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23872926\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3807\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3807|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/21/22875\" title=\"table 1\">",
"      Infections in residents of LTCF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/49/12060\" title=\"table 2\">",
"      LTCF IC program guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/41/28315\" title=\"table 3\">",
"      Resistant bacteria in LTCFs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/34/26152?source=related_link\">",
"      Important sites and pathogens causing infections in long-term care facilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_490="Screening for sexually transmitted infections";
var content_f0_30_490=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Screening for sexually transmitted infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/490/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/490/contributors\">",
"     Heidi Swygard, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/490/contributors\">",
"     Myron S Cohen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/490/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/490/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/490/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/30/490/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/30/490/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/30/490/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexually transmitted infections (STIs) are a major public health problem in developed and developing countries. Complications of untreated STIs include upper genital tract infections, infertility, cervical cancer, and enhanced transmission and acquisition of the human immunodeficiency virus (HIV).",
"   </p>",
"   <p>",
"    The approach to STI diagnosis and management is based upon disease or symptom-specific syndromes, including vaginal discharge, urethral discharge, ulcerative genital disease, nonulcerative genital disease, and pelvic pain. However, many patients have asymptomatic disease, which increases the risk of complications and sustained transmission in the community. Unfortunately, routine screening of all patients is cost-prohibitive, particularly in resource-poor countries [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/1\">",
"     1",
"    </a>",
"    ]. Targeted screening of asymptomatic patients in specified risk groups is important and has been shown to be effective.",
"   </p>",
"   <p>",
"    STI screening, including targeted screening and prevention, will be discussed here. In its 2010 guidelines on the treatment of sexually transmitted infections, the United States Centers for Disease Control and Prevention (CDC) also made recommendations on screening [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. The recommendations in this topic are largely consistent with those guidelines.",
"   </p>",
"   <p>",
"    The approaches to patients with specific genitourinary symptoms and signs are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12538?source=see_link\">",
"     \"Approach to the patient with genital ulcers\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    .) The prevention of STIs is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Information on the clinical presentation, diagnosis, and treatment of specific STIs are reviewed in detail separately. (See related topics). Sexually transmitted infections and HIV infection in adolescents are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37689?source=see_link\">",
"     \"Sexually transmitted diseases: Overview of issues specific to adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1737?source=see_link\">",
"     \"The adolescent with HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TAKING A SEXUAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the assessment of sexually transmitted infection (STI) risk, it is important to obtain a thorough sexual history including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Any new sexual partner(s)",
"     </li>",
"     <li>",
"      History of multiple sexual partners",
"     </li>",
"     <li>",
"      History of genital ulceration (which can increase the risk of HIV acquisition)",
"     </li>",
"     <li>",
"      History of sexual intercourse with trauma (which can increase the risk of acquisition of hepatitis B or C)",
"     </li>",
"     <li>",
"      Types of sexual exposures (which will guide decisions about which mucosal sites to test diagnostically)",
"     </li>",
"     <li>",
"      Frequency of condom use",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The history should be straightforward and non-judgmental with appropriate counseling regarding risk-taking behaviors, as necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/3\">",
"     3",
"    </a>",
"    ]. Some medical providers do not routinely obtain a sexual history. In one study, only 70 percent reported \"always\" or \"almost always\" obtaining a sexual history in adolescent females [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/4\">",
"     4",
"    </a>",
"    ]. One reason for this omission may be related to provider comfort with this part of the patient interview [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. Suggestions for open-ended, non-judgmental questions, as suggested by the Centers for Disease Control and Prevention (CDC), are found in the following table (",
"    <a class=\"graphic graphic_table graphicRef61677 \" href=\"UTD.htm?36/21/37212\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]&nbsp;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for sexually transmitted infections include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/5-12\">",
"     5-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Young age (15 to 24 years old)",
"     </li>",
"     <li>",
"      African-American race",
"     </li>",
"     <li>",
"      Unmarried status",
"     </li>",
"     <li>",
"      Geographical residence",
"     </li>",
"     <li>",
"      New sex partner in past 60 days",
"     </li>",
"     <li>",
"      Multiple sexual partners",
"     </li>",
"     <li>",
"      History of a prior STI",
"     </li>",
"     <li>",
"      Illicit drug use",
"     </li>",
"     <li>",
"      Admission to correctional facility or juvenile detention center [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Meeting partners on the internet [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Contact with sex workers",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients who seek screening for sexually transmitted infections (STIs) should receive testing and counseling for HIV infection. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Human immunodeficiency virus (HIV)'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The optimal interval for screening of STIs is uncertain. For women with prior negative screening, the interval for reevaluation will be influenced by a change in risk factor profile. For previously infected women, rescreening at three to four months is appropriate due to high rates of reinfection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of reinfection was examined in 2419 men and women who were evaluated in three urban STI clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients had follow-up visits scheduled at 3, 6, 9, and 12 months with the following results [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 1236 women, 26 percent had acquired one or more new infections (including C. trachomatis, N. gonorrhea and T. vaginalis).",
"     </li>",
"     <li>",
"      Among 1183 men, 15 percent had acquired one or more new infections (including C. trachomatis and N. gonorrhea).",
"     </li>",
"     <li>",
"      Furthermore, 66 percent of patients with new infections were asymptomatic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors concluded that men and women with newly diagnosed chlamydial, gonococcal, or trichomonas infections should be rescreened in three months for new asymptomatic infections. Clinicians should also consider the characteristics of the communities they serve when determining appropriate screening strategies for their particular patient population. Local public health authorities can be a source of valuable information regarding local patterns of infection and disease prevalence.",
"   </p>",
"   <p>",
"    The advent of urine-based tests and utility of self-collected vaginal swabs has increased the acceptance of STI screening among patients and providers since it allows for routine specimen collection without a pelvic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Urine screening has also led to increased screening of men.",
"   </p>",
"   <p>",
"    Other clinical considerations for STI screening include the diagnosis of an STI in the sex partner.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Human immunodeficiency virus (HIV)",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients being evaluated for sexually transmitted infections (STIs) should be offered counseling and referral for HIV testing [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2,16-18\">",
"     2,16-18",
"    </a>",
"    ]. Counseling provides an opportunity for risk reduction education as well as diagnosis of HIV infection. Diagnosis of HIV benefits the patient who may need to initiate antiretroviral therapy due to advanced immunosuppression and the public's health when the source patient is counseled regarding preventive measures.",
"   </p>",
"   <p>",
"    Recommendations for HIV screening in the Centers for Disease Control (CDC) guidelines include opt-out screening and annual screening for those at high risk for HIV infection. For pregnant women, HIV testing is recommended in the first trimester and again in the third trimester in areas with increased rates of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. These recommendations are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/34/10793?source=see_link\">",
"     \"Serologic screening for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibody screening can be accomplished either through a rapid test or enzyme immunoassay (EIA). Reactive antibody tests need to be confirmed by supplemental testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to recognize that some patients with STIs may also have very recently acquired HIV infection (acute HIV). Patients with acute HIV infection often have complaints of a fever, \"mono-like illness\", or diarrhea not common among STI patients. Diagnosis of acute HIV infection during this \"window period\" is made by measuring HIV RNA [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=see_link\">",
"     \"Acute and early HIV infection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Gonorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;During 2008, a total of 336,742 cases of gonorrhea were reported in the United States; the reported gonorrhea rate among women (119.4 per 100,000) was greater than that reported for men (103 per 100,000) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6\">",
"     6",
"    </a>",
"    ]. In the United States, the highest attack rates are seen in sexually active 15- to 19-year-old women (636.8 cases per 100,000) and 20- to 24-year-old men (433.6 cases per 100,000). Overall, rates in African-Americans continue to decline but are still 20 times higher than those seen in whites.",
"   </p>",
"   <p>",
"    Gonococcal infection can lead to urethritis, cervicitis, pharyngitis, and anorectal infection. Since untreated gonococcal infection can lead to serious complications in women, including pelvic inflammatory disease and infertility, testing for Neisseria gonorrhoeae should be performed annually in asymptomatic women with one or more of the following risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sexually active women younger than 25 years",
"     </li>",
"     <li>",
"      Inconsistent condom use",
"     </li>",
"     <li>",
"      A history of multiple partners or a partner with multiple contacts",
"     </li>",
"     <li>",
"      Sexual contact with a partner with culture-proven STI",
"     </li>",
"     <li>",
"      A history of repeated episodes of STI",
"     </li>",
"     <li>",
"      Sex work or drug use",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most gonorrhea infections in men produce overt symptoms that lead to medical evaluation. While less common, asymptomatic disease in men contributes to sustained transmission in women. Among symptomatic heterosexual men, gonorrhea prevalence can be as high as 28 percent in some settings; however, the prevalence drops to 1.5 percent in asymptomatic men [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The US Preventive Services Task Force (USPSTF) found insufficient evidence to argue for or against routine gonorrhea screening in men [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/21\">",
"     21",
"    </a>",
"    ]. However, some high-risk groups, such as MSM, may benefit from routine screening. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Screening special populations'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Regardless of symptoms, sexual partners should be evaluated, tested, and treated if they had sexual contact with the index patient during the 60 days preceding onset of symptoms or diagnosis of chlamydia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current methods for the diagnosis of genital gonococcal infections include urethral Gram stain, culture on Thayer-Martin media, DNA probes, and DNA amplification techniques. The use of these tests is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=see_link&amp;anchor=H11473906#H11473906\">",
"     \"Diagnosis of gonococcal infections\", section on 'General background'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chlamydia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydia trachomatis is the most commonly reported STI in the United States, with 1,210,523 infections reported in 2008, a case rate of 401.3 per 100,000 population, a nearly 10 percent increase from 2007 (367.5 cases per 100,000) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6\">",
"     6",
"    </a>",
"    ]. Chlamydia infection can lead to urethritis, cervicitis, epididymitis, and proctitis. Untreated infections in women can lead to tubal pregnancy, infertility, and chronic pelvic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6,22\">",
"     6,22",
"    </a>",
"    ]. In men, chlamydial infection can result in infertility, chronic prostatitis, reactive arthritis, and urethral strictures.",
"   </p>",
"   <p>",
"    Since the majority of infected women do not exhibit clinical symptoms, the USPSTF and the CDC recommend annual screening of asymptomatic women for Chlamydia trachomatis infection in the following risk groups [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6,16,23\">",
"     6,16,23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All sexually active women age 25 years or younger (including pregnant women)",
"     </li>",
"     <li>",
"      Sexually active women older than 25 years with risk factors (eg, a new sex partner in prior 60 days, more than one sex partner, inconsistent condom use, unmarried, or history of STI)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Screening programs have been demonstrated to decrease rates of pelvic inflammatory disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/24\">",
"     24",
"    </a>",
"    ]. The USPSTF made no recommendation for or against routine screening of asymptomatic low-risk women in the general population and cited insufficient evidence for or against routine screening of asymptomatic men. The USPSTF clinical practice guideline for screening for chlamydial infection, as well as other USPSTF guidelines, can be accessed through the website for the Agency for Healthcare Research and Quality at",
"    <a class=\"external\" href=\"file://www.ahrq.gov/clinic/uspstfix.htm\">",
"     www.ahrq.gov/clinic/uspstfix.htm",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CDC suggests focused screening of sexually active men in settings associated with a high prevalence of chlamydia infections (eg, correctional facilities and STI clinics) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. Screening of sexually active men who have sex with men (MSM) can also be considered. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Men who have sex with men'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Testing for chlamydia infection can be performed with nucleic acid amplification techniques (NAAT) on cervical or urine specimens [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. Diagnosis and treatment of chlamydial infections is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Trichomoniasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trichomoniasis is caused by the protozoan T. vaginalis. Symptoms can include urethritis in males and diffuse malodorous vaginal discharge with vulvar irritation in females.",
"   </p>",
"   <p>",
"    Infection can also be asymptomatic in men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. One prospective, multicenter study among male partners of women with trichomoniasis demonstrated that 72 percent of male partners were infected with T. vaginalis, and of those infected, the vast majority (77 percent) were asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/25\">",
"     25",
"    </a>",
"    ]. Detection of this organism in the male partners was optimized using PCR of urine samples; urine cultures detected 8 percent of infections compared to 70 percent with PCR-based techniques. The only factor that predicted T. vaginalis infection in the male partner was a high vaginal pH in the female partner; the mechanism by which pH alterations might enhance T. vaginalis acquisition or transmission is unknown.",
"   </p>",
"   <p>",
"    The CDC recommends screening for T. vaginalis in women: a) with new or multiple partners; b) with a history of STIs; c) who trade sex for drugs or money; d) who use injection drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. The diagnosis of trichomonas in a female patient can be made by microscopy, rapid antigen testing, nucleic acid amplification testing, and culture. Among men, microscopy has poor sensitivity; culture or NAATs is preferred for male patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. Diagnostic testing is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=see_link\">",
"     \"Trichomonas vaginalis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some studies have suggested that vaginal trichomoniasis is also a risk factor for HIV acquisition:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, 1335 HIV-seronegative women in Kenya were monitored for a median of 566 days for HIV seroconversion and acquisition of T. vaginalis [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/26\">",
"       26",
"      </a>",
"      ]. There were 806 incident T. vaginalis infections and 265 women seroconverted to HIV. Trichomoniasis was associated with a 1.5-fold (95% CI 1.04-2.24-fold) increased risk of HIV acquisition after adjustment for potential confounding factors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=see_link\">",
"       \"Trichomonas vaginalis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In another longitudinal study performed in Uganda and Zimbabwe, PCR testing for T. vaginalis infection was performed on cervical samples from 213 women who experienced HIV seroconversion (cases) and in cervical samples from 4450 HIV-uninfected women (controls) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/27\">",
"       27",
"      </a>",
"      ]. In a multivariate analysis controlling for hormonal contraception, other STIs, and behavioral and demographic factors, the adjusted odds ratio for HIV acquisition was 2.7 for women who had evidence of T. vaginalis infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diagnosis and treatment is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=see_link\">",
"     \"Trichomonas vaginalis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=see_link\">",
"     \"Genital Chlamydia trachomatis infections in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Syphilis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from the CDC demonstrated that there was an almost 20 percent increase in the number of cases of primary and secondary syphilis from 2007 to 2008 (up from 11,466 to 13,500 cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6\">",
"     6",
"    </a>",
"    ]. Among men who have sex with men (MSM), the case rate increased 15 percent (6.6 cases per 100,000 in 2007 to 7.6 cases in 2008) while the rate increased 36 percent among women (1.1 cases to 1.5 cases per 100,000). The rates increased among all",
"    <span class=\"nowrap\">",
"     race/ethnicities",
"    </span>",
"    with the exception of American",
"    <span class=\"nowrap\">",
"     Indian/Alaskan",
"    </span>",
"    natives [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/6\">",
"     6",
"    </a>",
"    ]. There is also a relatively high rate of HIV coinfection in persons with syphilis. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'HIV-infected patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following groups are at increased risk for syphilis and should be screened [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      All pregnant women at the first prenatal visit (and during the third trimester and at delivery for women in high-risk groups). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Pregnant women'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Commercial sex workers",
"     </li>",
"     <li>",
"      Persons in correctional facilities",
"     </li>",
"     <li>",
"      Persons diagnosed with another STI",
"     </li>",
"     <li>",
"      MSM who engage in high-risk behaviors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Syphilis testing has classically consisted of an initial, inexpensive nontreponemal test (eg, RPR, VDRL) with confirmation using a more specific treponemal test (eg, MHA-TP, FTA-ABS).",
"   </p>",
"   <p>",
"    However, for cost reasons, some high-volume laboratories have begun testing with the more specific (and automated) treponemal testing first, followed by testing with the nontreponemal test (when the treponemal test is positive). This reversal of procedures has lead to questions about test interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/30\">",
"     30",
"    </a>",
"    ]. This non-traditional testing algorithm is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link\">",
"     \"Diagnostic testing for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Task Force recommended against routine screening of asymptomatic persons who are not at increased risk of syphilis, since most positive tests in this setting represent false positives. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnostic testing for syphilis\", section on 'Testing algorithms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Herpes simplex virus type 1 and type 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;An estimated 25 percent of the US population has serological evidence of herpes infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/31\">",
"     31",
"    </a>",
"    ]. Asymptomatic shedding of the virus is not uncommon, although many infected patients are also unaware of being infected [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since active disease causes ulcerative lesions, herpes infection is believed to increase the risk of HIV transmission and acquisition. However, the USPSTF recommends against routine serological screening for herpes in asymptomatic persons [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HSV-2 has also been associated with other sexually transmitted infections. In one prospective study of Kenyan sex workers, prevalent HSV-2 infection was linked to prevalent bacterial vaginosis, although the direction of causality could not be determined [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/34\">",
"     34",
"    </a>",
"    ]. HSV-2 was also co-incident with gonorrhea, trichomoniasis, and syphilis infections.",
"   </p>",
"   <p>",
"    The diagnosis of HSV infection can be confirmed by viral culture, polymerase chain reaction (PCR), direct fluorescence antibody, Tzanck preparation, and type-specific serologic tests. The choice of test varies with the clinical presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hepatitis A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although hepatitis A is more commonly a cause of food-borne outbreaks, it can be transmitted through some forms of intimate and sexual contact. Hepatitis A screening should be offered to MSM and injection drug users (IDU). If susceptible, vaccination should be offered in these patient groups. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatitis B is efficiently transmitted by percutaneous or mucous membrane exposure to infected blood or body fluids that contain blood. Hepatitis B screening (hepatitis B surface antigen with anti-HBc or anti-HBs) should be offered to patients with multiple sex partners, MSM, and injection drug users. If the patient is susceptible, vaccination should be offered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31690?source=see_link\">",
"     \"Hepatitis B virus vaccination\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42279?source=see_link\">",
"     \"Serologic diagnosis of hepatitis B virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hepatitis C",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual transmission of hepatitis C is much less efficient than through injection drug use. Risk factors for sexual transmission include exposure to an infected partner or exposure to multiple sex partners. Case reports of acute hepatitis C among HIV-positive MSM have suggested that the risk of HCV transmission may be increased in the setting of genital ulcerative disease (eg, syphilis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatitis C antibody testing is recommended for routine screening in asymptomatic persons based on their risk for infection or recognized exposure (eg, IDU, hemodialysis) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. Another setting in which HCV antibody screening may be considered is the sex partner of a patient who has been diagnosed with hepatitis C, particularly if there is a history of traumatic anal receptive sexual intercourse. Screening for hepatitis C is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link&amp;anchor=H2#H2\">",
"     \"Screening for and diagnosis of chronic hepatitis C virus infection\", section on 'Who should be tested'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No vaccine is available for hepatitis C. Those individuals who are HCV-seropositive should be referred for further evaluation to determine if their disease is active. Information should also be given regarding transmission to decrease the risk of HCV transmission to others. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"     \"Epidemiology and transmission of hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Human papillomavirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent viral infection with specific high-risk genotypes of human papillomavirus (HPV) causes virtually all cancers of the cervix. In the United States, guidelines issued by various professional organizations strongly recommend screening for cervical cancer, although there are minor differences in the recommended screening parameters (",
"    <a class=\"graphic graphic_table graphicRef82951 \" href=\"UTD.htm?24/21/24925\">",
"     table 2",
"    </a>",
"    ). Cervical cancer screening policies in other countries also differ by starting age, stopping age, and frequency (",
"    <a class=\"graphic graphic_table graphicRef72903 \" href=\"UTD.htm?11/32/11790\">",
"     table 3",
"    </a>",
"    ). These recommendations are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=see_link&amp;anchor=H32#H32\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Recommendations of professional organizations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific screening recommendations for HIV-infected women are also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36934?source=see_link\">",
"     \"Screening for cervical cancer in HIV infected women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=see_link&amp;anchor=H15#H15\">",
"     \"HIV and women\", section on 'Abnormal cervical cytology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a woman (aged &gt;21) has not had a Pap test within the recommended screening interval, cervical screening should be considered at the time of evaluation for an STI [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2,35\">",
"     2,35",
"    </a>",
"    ]. In a review of 1000 female STI clinic attendees who had a Pap smear performed as part of their clinical evaluation, 5.7 percent had an abnormal result [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/36\">",
"     36",
"    </a>",
"    ]. Increasing age, genital warts, and chlamydia infections were independently associated with an abnormal Pap smear in multivariate analysis.",
"   </p>",
"   <p>",
"    The presence of a mucopurulent discharge should not delay cervical cytologic examination; women who are menstruating should return for screening at the earliest opportunity [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. The sequence of Pap testing in relation to collection of other cervicovaginal specimens does not appear to influence the Pap test results.",
"   </p>",
"   <p>",
"    Women between the ages of 9 and 26 years are recommended to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/35/43574?source=see_link\">",
"     human papillomavirus vaccine",
"    </a>",
"    to prevent cervical dysplasia and cervical cancer. Routine vaccination is recommended for females between the ages of 11 and 12 years, but the vaccination series may be started as early as nine years, and females age 13 to 26 years can benefit from the vaccine as well [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Pap smears and HPV DNA or antibody testing is not required before starting the series. However, clinicians need to be aware that HPV immunization is NOT effective in clearing cytologically evident disease or infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Quadrivalent HPV vaccine can also be used in males and females aged 9 to 26 years to prevent genital warts and anogenital cancers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SCREENING SEXUALLY ACTIVE PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, all sexually active men and women should be offered routine testing for HIV infection. Also serologic screening for hepatitis B should be performed; if the patient has no evidence of prior exposure or vaccination, then immunization against hepatitis B should be offered. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Human immunodeficiency virus (HIV)'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H13\">",
"     'Hepatitis B'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Women with a history of unprotected sex or multiple sex partners should be screened annually for gonorrhea and chlamydia. Annual cervical screening should also be included. Females between the ages of 9 and 26 years should be offered",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/35/43574?source=see_link\">",
"     human papillomavirus vaccine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Men with a history of unprotected sex or multiple sex partners should be screened annually for chlamydia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some proponents have argued that school-based health centers should implement systematic screening programs in adolescents, who are at high risk of STI acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of high rates of reinfection, patients diagnosed with gonorrhea should be advised to retest in three months; for patients who fail to be retested in that time period, clinicians should consider repeating gonorrhea testing in the 12 months following the initial diagnosis. Retesting should not be confused with a test of cure; test of cure is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SCREENING SPECIAL POPULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening recommendations vary by risk group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrauterine or perinatally transmitted sexually transmitted infections (STIs) can have severely debilitating effects on pregnant women, their partners, and their fetuses. Infections of concern include herpes, hepatitis B, chlamydia and gonorrhea, syphilis, HIV and hepatitis C [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/40\">",
"     40",
"    </a>",
"    ]. Screening for these infections is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link\">",
"     \"Initial prenatal assessment and patient education\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Men who have sex with men",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following screening tests should be offered to sexually active men who have sex with men (MSM) on at least an annual basis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV antibody",
"     </li>",
"     <li>",
"      Urethral or urine test (culture or nucleic acid amplification) for gonorrhea and chlamydia. The choice of test will depend on issues of cost, convenience, and feasibility, which may vary in different settings.",
"     </li>",
"     <li>",
"      Pharyngeal culture for gonorrhea in men with history of oral-genital exposure; testing for chlamydia pharyngeal infection is not recommended.",
"     </li>",
"     <li>",
"      Rectal gonorrhea and chlamydia screening in MSM who have had receptive anal intercourse in the past year.",
"     </li>",
"     <li>",
"      Syphilis serology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More frequent screening (eg, every three to six-month intervals) is recommended by the Centers for Disease Control (CDC) for MSM who have multiple or anonymous partners.",
"   </p>",
"   <p>",
"    One study determined the proportion of gonorrhoeae infections in MSM that would be missed if only urethral or urine specimens were tested. Over a seven-year period, 7333 MSM attending a STI clinic in the United States underwent culture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    NAAT sampling of multiple sites [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/41\">",
"     41",
"    </a>",
"    ]. The study demonstrated that one-third of the total number of gonorrhoeae cases would have been missed if only urethral or urine samples were tested. Similar findings have been reported in HIV-infected MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening for evidence of past hepatitis B and hepatitis A infection should also be performed in this population as well; if the patient is seronegative, immunization with both vaccines should be offered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31690?source=see_link\">",
"     \"Hepatitis B virus vaccination\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=see_link\">",
"     \"Hepatitis A virus vaccination and postexposure prophylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should also be offered testing for hepatitis C antibody, since there is increasing evidence of sexual transmission among MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/43\">",
"     43",
"    </a>",
"    ]. For those MSM who are HIV-infected, ongoing screening for hepatitis C is warranted to detect acute infection. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'HIV-infected patients'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    More frequent screening may be needed in those at highest risk (patients who acknowledge having multiple anonymous partners or having sex in conjunction with drug use) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Routine testing for anal cytologic abnormalities or anal HPV infection is not recommended until more data are available on the reliability of screening methods [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Women who have sex with women",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of infection with STIs among women who have sex with women varies widely, depending upon number of partners, if the patient is bisexual, and specific sexual practices. As an example, practices involving digital-vaginal or digital-anal contact, particularly with shared penetrative sex items, are a possible means for transmission of infection.",
"   </p>",
"   <p>",
"    Diagnostic testing for sexually transmitted infections should be performed in women with symptoms and annual screening for chlamydia and syphilis should be performed among WSW who are sexually active [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    HPV DNA has been detected from the cervix, vagina, and vulva in approximately one-third of women who have sex with women and high and low-grade squamous intraepithelial lesions have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/44\">",
"     44",
"    </a>",
"    ]. Thus, women who have sex with women should undergo routine cervical cancer screening and HPV immunization according to standard guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic is discussed elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25113?source=see_link\">",
"     \"Medical care of women who have sex with women\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     HIV-infected patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;High rates of STIs have been found through screening programs of HIV-infected patients in the United States and abroad [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/45\">",
"     45",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of routine screening for syphilis, gonorrhea, and chlamydia among 814 asymptomatic HIV-infected patients, 1.8 percent of patients were diagnosed with syphilis and 10 percent were diagnosed with chlamydia or gonorrhea; 88 percent of these cases occurred at nonurethral sites [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a 10-year prospective study of female sex workers in Kenya, 238 women of a cohort of 1215 subjects had documented HIV seroconversion [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/47\">",
"       47",
"      </a>",
"      ]. HIV infection was associated with a significantly higher incidence of genital ulcer disease, which increased with progressive levels of immunosuppression.",
"     </li>",
"     <li>",
"      The estimated rate of primary and secondary syphilis in persons with HIV is higher than that of the general population. Of 6862 reported cases of syphilis in 2002 in the United States, 25 percent occurred in persons coinfected with HIV [",
"      <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Routine STI screening of HIV-infected patients in order to reduce the spread of STIs is recommended, particularly because STIs in turn can increase HIV transmission. Specifically, testing for the following infections is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/2,49\">",
"     2,49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neisseria gonorrhoeae, at initial evaluation then annually",
"     </li>",
"     <li>",
"      Chlamydia trachomatis, at initial evaluation then annually",
"     </li>",
"     <li>",
"      Syphilis, at initial evaluation then annually",
"     </li>",
"     <li>",
"      Hepatitis A (for MSM, those who are chronically infected with hepatitis B",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C, and injection drug users), at initial evaluation with vaccination if susceptible",
"     </li>",
"     <li>",
"      Hepatitis B, at initial evaluation with vaccination if susceptible",
"     </li>",
"     <li>",
"      Hepatitis C, at initial evaluation with antibody testing with at least annual screening for MSM, active injection drug or intranasal cocaine users, those who engage in unprotected sex, and those undergoing hemodialysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In areas of high STI prevalence, biannual STI testing may be prudent. More frequent screening for gonorrhea, chlamydia, and syphilis is indicated in HIV-infected MSM who have multiple or anonymous partners, as well as in patients who exchange sex for money, drugs or basic needs. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Men who have sex with men'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    However, up to 42 percent of healthcare providers (HCP) providing HIV care reported \"never\" or \"almost never\" performing initial STI screening in HIV-infected patients, and many healthcare providers do not ask patients about ongoing risk-taking behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/50\">",
"     50",
"    </a>",
"    ]. Of the 58 percent reporting some initial STI screening, almost one-third of these same HCP reported \"never\" to \"almost never\" performing annual gonorrhea or chlamydia testing in their HIV-infected women and men, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexual transmission of hepatitis C among HIV-infected MSM has increased internationally [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. Ongoing periodic screening in these men with liver function tests (LFTs) followed by hepatitis C antibody (HCV Ab) and RNA testing if abnormal is recommended to identify acute infection, which has a higher response rate to therapy than in the chronic setting. In a cost-effectiveness analysis, a screening strategy with yearly HCV Ab testing and LFTs with reflex RNA every six months was cost effective when the incidence of hepatitis C is below 1.25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/56\">",
"     56",
"    </a>",
"    ]. When the incidence is above 1.25 percent, screening with LFTs every three months was most cost effective.",
"   </p>",
"   <p>",
"    The incidence of anal cancer is also increasing among HIV-infected MSM. Screening is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=see_link\">",
"     \"Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with HIV should have cervical screening twice in the first year after diagnosis of HIV infection, and if the results are normal, annually thereafter. Women with abnormal cytology should be managed with colposcopy and gynecological consultation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=see_link\">",
"     \"HIV and women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     HEALTH DEPARTMENT NOTIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local and state public health practices of partner notification and disease reporting are important in addition to individual sexually transmitted disease case management. Notifiable infections include chancroid, chlamydia trachomatis, gonorrhea, acute hepatitis B, acute hepatitis C, HIV, and syphilis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PARTNER NOTIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Partners should be notified, examined, and treated for the sexually transmitted infection (STI) identified or suspected in the index patient. In some settings, partner delivered patient medication (PDPM) has been used. With this system, the patient directly provides their sexual contacts with medications and prescriptions to be filled. The PDPM approach does not give the sexual contact a chance to ask questions, or receive counseling or additional STD screening, but does prevent recurrent gonococcal and chlamydial infections [",
"    <a class=\"abstract\" href=\"UTD.htm?0/30/490/abstract/58\">",
"     58",
"    </a>",
"    ]. Clinicians need to be aware that PDPM is not legal in all states.",
"   </p>",
"   <p>",
"    Patients and their sex partners should abstain from sexual intercourse until seven days after a single-dose treatment or upon completion of a seven-day regimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/52/23362?source=see_link\">",
"       \"Patient information: Chlamydia and gonorrhea (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21906?source=see_link\">",
"       \"Patient information: Genital herpes (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/57/1940?source=see_link\">",
"       \"Patient information: Screening for sexually transmitted diseases (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"       \"Patient information: Gonorrhea (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=see_link\">",
"       \"Patient information: Chlamydia (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"       \"Patient information: Testing for HIV (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/3/36916?source=see_link\">",
"       \"Patient information: Genital herpes (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=see_link\">",
"       \"Patient information: Genital warts in women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"       \"Patient information: Hepatitis B (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=see_link\">",
"       \"Patient information: Hepatitis C (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for sexually transmitted infection (STI) acquisition include young age, unmarried status, residence in an urban area, new sex partner, multiple sex partners, history of STIs, illicit drug use, contact with sex workers, imprisonment, and meeting partners on the internet. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Our recommendations for screening are consistent with those of the Centers for Disease Control and Prevention, as outlined in the 2010 treatment guidelines for STIs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All patients being evaluated for STIs should be offered counseling and testing for HIV. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Human immunodeficiency virus (HIV)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hepatitis B screening should be offered to men who have sex with men (MSM), injection drug users (IDU), persons attending an STI clinic or seeking STI treatment, and persons with a history of multiple sex partners. Patients who are not immune should be offered vaccination. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Hepatitis B'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hepatitis A screening should be offered to MSM and injection drug users. Those who are not immune should be offered vaccination. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Hepatitis A'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asymptomatic women with risk factors for STIs should be screened for gonococcal or chlamydial infection annually. &nbsp;Males and females between the ages of 9 and 26 years should be offered human papillomavirus vaccination. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Gonorrhea'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Chlamydia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Human papillomavirus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following screening tests for sexually active MSM are recommended on at least an annual basis: HIV antibody, testing for gonorrhea and chlamydia, and syphilis serology. More frequent screening may be indicated in patients at high risk. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Men who have sex with men'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Syphilis screening is recommended for commercial sex workers, persons who exchange sex for drugs, and persons in correctional facilities. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Syphilis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnant women should be screened for gonorrhea, chlamydia, HIV, hepatitis B, and syphilis infections. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Screening special populations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HIV-infected patients should be screened annually for Neisseria gonorrhoeae, Chlamydia trachomatis, syphilis, and hepatitis B and C. Vaccination against hepatitis A and B is recommended for nonimmune patients. HIV-infected patients who actively use injection drugs or intranasal cocaine, engage in unprotected sex, are men who have sex with men, or are undergoing hemodialysis should have ongoing screening for hepatitis C. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'HIV-infected patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Local and state public health departments should be kept informed of notifiable infections, which include chancroid, chlamydia, gonorrhea, acute hepatitis A, acute hepatitis B, acute hepatitis C, HIV, and syphilis. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Health department notification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partners should be notified, examined, and treated for the STI identified in the index patient. Patients and their sex partners should abstain from sexual intercourse until therapy is completed. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Partner notification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/1\">",
"      Low N, Broutet N, Adu-Sarkodie Y, et al. Global control of sexually transmitted infections. Lancet 2006; 368:2001.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/3\">",
"      Torkko KC, Gershman K, Crane LA, et al. Testing for Chlamydia and sexual history taking in adolescent females: results from a statewide survey of Colorado primary care providers. Pediatrics 2000; 106:E32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/4\">",
"      Boekeloo BO, Marx ES, Kral AH, et al. Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health 1991; 81:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/5\">",
"      Ness RB, Smith KJ, Chang CC, et al. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006; 33:137.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2008. US Department of Health and Human Services, Atlanta, GA 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/7\">",
"      Bernstein KT, Zenilman J, Olthoff G, et al. Gonorrhea reinfection among sexually transmitted disease clinic attendees in Baltimore, Maryland. Sex Transm Dis 2006; 33:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/8\">",
"      Lofy KH, Hofmann J, Mosure DJ, et al. Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002. Sex Transm Dis 2006; 33:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/9\">",
"      Kerani RP, Handcock MS, Handsfield HH, Holmes KK. Comparative geographic concentrations of 4 sexually transmitted infections. Am J Public Health 2005; 95:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/10\">",
"      Niccolai LM, Ethier KA, Kershaw TS, et al. New sex partner acquisition and sexually transmitted disease risk among adolescent females. J Adolesc Health 2004; 34:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/11\">",
"      Klausner JD, Kent CK, Wong W, et al. The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex Transm Dis 2005; 32:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/12\">",
"      Kahn RH, Voigt RF, Swint E, Weinstock H. Early syphilis in the United States identified in corrections facilities, 1999-2002. Sex Transm Dis 2004; 31:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/13\">",
"      Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/14\">",
"      Hoebe CJ, Rademaker CW, Brouwers EE, et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis 2006; 33:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/15\">",
"      Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/16\">",
"      Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/17\">",
"      Campos-Outcalt D, Mickey T, Weisbuch J, Jones R. Integrating routine HIV testing into a public health STD clinic. Public Health Rep 2006; 121:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/18\">",
"      Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/19\">",
"      Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/20\">",
"      Gaydos CA, Kent CK, Rietmeijer CA, et al. Prevalence of Neisseria Gonorrhoeae among men screened for Chlamydia Trachomatis in four United States cities, 1999-2003. Sex Transm Dis 2006; 33:314.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for gonorrhea. Agency for Healthcare Research and Quality, Rockville, MD. Revised January 2006. file://www.ahrq.gov/clinic/uspstf/uspsgono.htm (Accessed on June 05, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/22\">",
"      Kohl KS, Markowitz LE, Koumans EH. Developments in the screening for Chlamydia trachomatis: a review. Obstet Gynecol Clin North Am 2003; 30:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/23\">",
"      US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med 2001; 20:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/24\">",
"      Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/25\">",
"      Se&ntilde;a AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/26\">",
"      McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/27\">",
"      Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for syphilis. Agency for Healthcare Research and Quality, Rockville, MD. Release date 2004. file://www.ahrq.gov/clinic/uspstf/uspssyph.htm (Accessed on June 05, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/29\">",
"      Wong W, Chaw JK, Kent CK, Klausner JD. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis 2005; 32:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/30\">",
"      Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008; 57:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/31\">",
"      Stanberry L, Cunningham A, Mertz G, et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res 1999; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/32\">",
"      Krone MR, Wald A, Tabet SR, et al. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for herpes. Agency for Healthcare Research and Quality, Rockville, MD. Release date 2005. file://www.ahrq.gov/clinic/uspstf/uspsherp.htm (Accessed on June 05, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/34\">",
"      Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/35\">",
"      Kamb ML. Cervical cancer screening of women attending sexually transmitted disease clinics. Clin Infect Dis 1995; 20 Suppl 1:S98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/36\">",
"      Kanno MB, Nguyen RH, Lee EM, et al. The prevalence of abnormal cervical cytology in a sexually transmitted diseases clinic. Int J STD AIDS 2005; 16:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/37\">",
"      Casey C, Vellozzi C, Mootrey GT, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/38\">",
"      Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/39\">",
"      Nsuami M, Taylor SN, Sanders LS, Martin DH. Missed opportunities for early detection of chlamydia and gonorrhea in school-based health centers. Sex Transm Dis 2006; 33:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/40\">",
"      Majeroni BA, Ukkadam S. Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician 2007; 76:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/41\">",
"      Gunn RA, O'Brien CJ, Lee MA, Gilchick RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003. Sex Transm Dis 2008; 35:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/42\">",
"      Rieg G, Lewis RJ, Miller LG, et al. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS 2008; 22:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/43\">",
"      G&ouml;tz HM, van Doornum G, Niesters HG, et al. A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications. AIDS 2005; 19:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/44\">",
"      Marrazzo JM, Koutsky LA, Kiviat NB, et al. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health 2001; 91:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/45\">",
"      Dang T, Jaton-Ogay K, Flepp M, et al. High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clin Infect Dis 2009; 49:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/46\">",
"      Phipps W, Stanley H, Kohn R, et al. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care STDS 2005; 19:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/47\">",
"      McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 2005; 191:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/48\">",
"      Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis 2005; 32:265.",
"     </a>",
"    </li>",
"    <li>",
"     file://hab.hrsa.gov/deliverhivaidscare/files/hepccoinfectguide2011.pdf (Accessed on July 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/50\">",
"      Hall CS, Marrazzo JD. Emerging issues in management of sexually transmitted diseases in HIV infection. Curr Infect Dis Rep 2007; 9:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/51\">",
"      Se&ntilde;a AC, Mertz KJ, Thomas D, et al. A survey of sexually transmitted diseases/HIV coinfection testing and reporting practices among health care providers in New Jersey. Sex Transm Dis 2005; 32:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/52\">",
"      van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009; 136:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/53\">",
"      van der Helm JJ, Prins M, del Amo J, et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011; 25:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/54\">",
"      Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011; 60:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/55\">",
"      Taylor LE, Holubar M, Wu K, et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011; 52:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/56\">",
"      Linas BP, Wong AY, Schackman BR, et al. Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clin Infect Dis 2012; 55:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/57\">",
"      Hopkins RS, Jajosky RA, Hall PA, et al. Summary of notifiable diseases--United States, 2003. MMWR Morb Mortal Wkly Rep 2005; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/30/490/abstract/58\">",
"      Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352:676.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7596 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-8C00B56BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_490=[""].join("\n");
var outline_f0_30_490=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TAKING A SEXUAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Human immunodeficiency virus (HIV)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Gonorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chlamydia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Trichomoniasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Herpes simplex virus type 1 and type 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hepatitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hepatitis C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Human papillomavirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SCREENING SEXUALLY ACTIVE PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SCREENING SPECIAL POPULATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Men who have sex with men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Women who have sex with women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      HEALTH DEPARTMENT NOTIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PARTNER NOTIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7596\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7596|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/21/37212\" title=\"table 1\">",
"      Five Ps of sexual history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/21/24925\" title=\"table 2\">",
"      US recs cerv cancer screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/32/11790\" title=\"table 3\">",
"      Intl cerv cancer screen policies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=related_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1562?source=related_link\">",
"      Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12538?source=related_link\">",
"      Approach to the patient with genital ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20345?source=related_link\">",
"      Diagnostic assays for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/35/16954?source=related_link\">",
"      HIV and women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/38/1641?source=related_link\">",
"      Hepatitis A virus vaccination and postexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31690?source=related_link\">",
"      Hepatitis B virus vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25113?source=related_link\">",
"      Medical care of women who have sex with women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/52/23362?source=related_link\">",
"      Patient information: Chlamydia and gonorrhea (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/3/36916?source=related_link\">",
"      Patient information: Genital herpes (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21906?source=related_link\">",
"      Patient information: Genital herpes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=related_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=related_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=related_link\">",
"      Patient information: Hepatitis C (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/57/1940?source=related_link\">",
"      Patient information: Screening for sexually transmitted diseases (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=related_link\">",
"      Patient information: Testing for HIV (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35018?source=related_link\">",
"      Prevention of sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=related_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=related_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36934?source=related_link\">",
"      Screening for cervical cancer in HIV infected women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42279?source=related_link\">",
"      Serologic diagnosis of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/34/10793?source=related_link\">",
"      Serologic screening for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37689?source=related_link\">",
"      Sexually transmitted diseases: Overview of issues specific to adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1737?source=related_link\">",
"      The adolescent with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=related_link\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_30_491="Clinical differential of microcystic adnexal carcinoma";
var content_f0_30_491=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical differential diagnosis of microcystic adnexal carcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Basal cell carcinoma, infiltrative or morpheaform type",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Desmoplastic squamous cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scar",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other adnexal carcinomas",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_491=[""].join("\n");
var outline_f0_30_491=null;
var title_f0_30_492="Reducing lead absorption";
var content_f0_30_492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Steps to take to minimize lead absorption in your family",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Make sure that your children wash their hands and face before eating and sleeping.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Prevent your children from eating things other than food (eg, dirt, paint).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Make sure that all surfaces (floors, countertops, tabletops, etc) have been thoroughly cleaned with a high phosphate detergent. This is especially important for toddlers since they crawl and lay on the floor and frequently put their hands in their mouths.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. If your home was built prior to 1977, it is extremely important to remove any flaking or peeling paint in the house, since older homes frequently were painted with lead-based paint. Painting over lead-based paint, or applying wallpaper, are only temporary ways to control exposure, and are not acceptable means of control. Protective equipment and respirators must be worn in the removal of lead-based paint from walls and woodwork. Consult a professional experienced in lead paint removal before doing this work.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Make sure that your children receive the recommended daily allowance of multivitamins with iron. They should have well-balanced diets, and drink plenty of milk (2-3 cups) each day. (Maximum amount of milk - 24 oz/day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Do not use herbal or folk medicine (these may contain lead).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. If you are not sure that your pottery does not have a lead glaze, use it only for decoration.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8. Store food in glass, plastic, or stainless steel containers, not in open cans.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9. Use water from the cold tap for cooking and drinking. Let it run for several minutes before collecting for use.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10. Be careful to keep materials for hobbies, such as those used for making ceramics or stained glass, away from children and areas where they spend time.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_492=[""].join("\n");
var outline_f0_30_492=null;
var title_f0_30_493="rMPI CP prog";
var content_f0_30_493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Myocardial perfusion imaging for acute chest pain: Prognostic data",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Duration of f/u",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Endpoint",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Event rate, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Normal scan",
"       </td>",
"       <td class=\"subtitle2\">",
"        Equivocal scan",
"       </td>",
"       <td class=\"subtitle2\">",
"        Abnormal scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993; 22:1804.",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        18 m",
"       </td>",
"       <td>",
"        Death, MI, revasc",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        N/A",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hilton TC, Thompson RC, Williams HJ, et al. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994; 23:1016.",
"       </td>",
"       <td>",
"        102",
"       </td>",
"       <td>",
"        3 m",
"       </td>",
"       <td>",
"        Death, MI, revasc",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        71",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997; 29:116.",
"       </td>",
"       <td rowspan=\"2\">",
"        1187",
"       </td>",
"       <td rowspan=\"2\">",
"        12 m",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td rowspan=\"2\">",
"        N/A",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Death",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998; 31:1011.",
"       </td>",
"       <td rowspan=\"4\">",
"        357",
"       </td>",
"       <td rowspan=\"4\">",
"        In-hospital",
"       </td>",
"       <td>",
"        AMI",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"       <td rowspan=\"4\">",
"        N/A",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cath",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CAD",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Revasc",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Udelson JE, Beshansky JR, Ballin DS, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002; 288:2693.",
"       </td>",
"       <td rowspan=\"2\">",
"        1215",
"       </td>",
"       <td rowspan=\"2\">",
"        30 d",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        10.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MI, death, revasc",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        6.1",
"       </td>",
"       <td>",
"        20.5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MI: myocardial infarction; revasc: revascularization; CAD: coronary artery disease.",
"    </div>",
"    <div class=\"reference\">",
"     Soman P, Udelson JE. Imaging patients with chest pain in the emergency department. In: Nuclear Cardiology: State of the art and future directions, 3rd ed, Mosby, Philadelphia 2005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_493=[""].join("\n");
var outline_f0_30_493=null;
var title_f0_30_494="Amniochorionic inflammation";
var content_f0_30_494=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amniochorionic inflammation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 314px; background-image: url(data:image/gif;base64,R0lGODlhRgE6AcQAAP///4CAgH9/fwAAAL+/vz8/P0BAQC8vL+/v78DAwN/f38/Pz19fX5+fn09PTx8fH6+vr4+Pj29vb6CgoODg4GBgYA8PDyAgIBAQENDQ0HBwcPDw8DAwMLCwsJCQkFBQUCH5BAAAAAAALAAAAABGAToBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSNhQBlpeYmZqbnJ2en6ChoqOkpaacE5M+CQ8Crq+wsbKztLW2t7i5uru8vb6yDAaqPQkFw1wEwsc6xctayc45zdFX0NQ209dU1toz2d1R3OAw3+NO4uYt5VALCjMLCCwSCy8ELvDVyuku608WxjLmsShgzwVAefSsoNunol+TBgweuAPQAIIDBwgEFIggQgCEAgxENHBH4GJBBAwK/0hAsPHixAYg3SloQEAAAJsUYwKYqZEjRXcLHGyUspAhCodMHECQ4FMlgggHCCCQCGBAAwAOrhJUIJGruwNXISxwGiFkA4wEHgAgYMGBzQEU0apNK5Xq1gfwfEIpatQEUiUILABYcEAEwbUAD8O9aZNgBJwCIhAmcZiAMQcFCyywPAIuZsObE9tzLKEK374k/iZp8K/AAHeVRVft2LgmZAGcR8QGcJg3gdyzexPMfZigK9P6UB89CEWpCKa+ERu2t/g4wcm84Vlwh0DB7gilp0oXARc8APHER/9WO5hocuV+mTsJPGLy7ujVa988cAAnhAMFFOCdPZyhxB8E481m4P8BCKYXnQAAOuAefCmoRmEPp8Fn4YU7ZKjchhzm4CFqIIZ4w4h9OfQbAROxgEBCIixQWgsHKeATBK7A2MOLKSDwm44kfCSBQEMo0CIMKBrl0ACuCBXPCjKSANwKiwEgAYISYAZTQSr09kKUKCgQ0VUmcIUAS1z2cBxFZMaQJENLjgBTRyA9qRED7VyVUQFCrVUQThIEiOBshpFHAgIQFEQAgho50M4DDNgUVAGDeuRUSvbMRCeeUgK0KKY3tWKZPYFS2pGQKB3GUwENBOUASUIxEE+AAijw204pkVmRSye8uU+cI+AlgU0fWRnSAokaM2xOjBkKAIJTubPYUoYpNVH/sbxBEIGEyCJwQAQsHqAAmlVd5dICcyl77KAi5KaRAuhSFNWAz55HlVVYvRovXVMJ8NSx7pQFAAMMSHXcA1JlxdtKApvgazrATmfBK3BZ8KR0Fku35mIEBGoBdSIwMNFTDjxwQDxdqdUAWAkdFkEBrsBM6MYYX9wpbYY62HEBH8+ME1w6G0MygM0yNla7Et5XwsPmRAzAAwgMsCLII3DGsTE0/0ePYucVZkKkAJQF3VoStPJgwb9Ji/NsVqPg7s/jEaQ1fmsDLRtn3/qI9W25caa0lO+FGDEDpQ3VHqsx4m1PseYpAJcA4UU1WwNt6qXwVFAPFk+xpqb1JD355WwM/+LtVQ0QzelB3jXVqN9tzADxzKl6sxlHFt2UVQfO4ZIB9icCAg7wx22AlHJGmAMp2asSXN7yKTlcBVwcUQG+hzzjf9TTg7281CMYOtvGjCVofQdYUFrr0zUfPOtwB03RAyAZowCACxz33wGy3i5fu7pfWKIQCpDQCqjyCKaN439BWACQTACRSBgQHAg00Qwe2I0IStBN/aOQBS9YjwxqaH8c7JAHP9SKX5jwhCiMBaRSyMIW7iIYIazEKWZIwxpq4gIVsKEOd0iKVIQwDwZIwA+H+IMgEvGIOzAiEpdoAyUy8YkxcCIUp8gCKVLxiiewIha3KAItchGLXvwiFcMoRv8okrGMTDwjGpGoxjUSsY1u/CEc42giCgzgjnccIR1NdAE8DsADe1xiBfyYgUAisQN4xIAhkbgBPFZgkUjkwB19CMkhauCOFKgkERMwgAto8ogD0MAn39iBUQ7RAxswpSpXycpWuvKVKJAhD3dISVjOgRUubCEMbUmHDf6Agrz8gi99AMxgdmGYGNKjMc2ATB4Uc5laaKYIoQmHbPhoavRgkQiMtJOpjcBfm5HKWlSwwGdS8wrZUIArVniVAXjtOBp5xe8K0wBIqe0EM6lS7s7pjVn68xIV2J+XmHQVeOJETmTqjT6lJICFriWI/4woJoT4wwAYQKI8DKgJBuqtZgn/AG0TOdl0nIUChyYjARiN6EWHaIksrGOgN2kAPGGGG1zppiBVggnpCAW4L7S0ogFwqUC5xLz+2GRNz2GXQlVgUmVK4achhKoVXkrUjpgNqbyhDE6Z6jCnRkGqFwQrFajamd9NrGhkG4EELHAA0BGvTTkZwE4f6tOgAlWoN+CUiLwKBbGayK9SQCZcT8TXJwCWQ4eFgjR1YE4jJJZCj3XCYvdaV5baFZ0gZEJjixBZ5XSWCbjMZQp32YXP9sW0SpClDXFIy8redQ5zXANqGTLbMcRWDbVNR27DcNs07HYcv/1Cb9EQ3G4UtwvDPcNxr7HcLSTXDM2NRnSz8NwyTHcZ/9e9QnXJkN1hdLcK2x3Ddycx3imEVwzljUR6o3DeMKz3EYlFaUrnmwnW0ve+E2XBex2RWIvi978Apu9KV7DfRvT3sq9VQYEZceAjRnbBi2gwER+M4LBWuAQQZvCFTZDhREjYsvrdcIg+nOAUdBgRJI6qiElw4kOkmIMUBrGJVzxiGougxYZ4sYVDLGMU4NjFNgbAjwmhYwnGuMQcDjJkgzzkQRT5r0xWMmqeXGMeIxnDUvZslHt8giYTectXZnGWmVGBPuIRhxQFbZn9iGYlHFnFCh7zDShgAHfiZkUQGoABMpkEOtt5anneMxLeDGMa73cCGJBcrw6AgVoSAdGKdv8Yox0tBELveMZFmMAAQrICBgyA0kDQNKdV4GlQ/8DSRja0nGdAAQyMutMY4LMQWv1qUseas2B+RJpHQIEEJCCTGUglCjoQgF2LOc5EMIDXXHCAws5A2TBoNq6tbAIKyHoEvhbiBgp5gg14IADcZoMdrw2ABBjAiGG8aALCjWVkC4GTaWIBAQZgbGJIDUn0JgKqRVCBR2J4AEE1d7cvMIEOcKDeys1hkruI8An4G9MQD0IFll2C7qDgAA//wcRRYPETYFzfuSbBBs4tbBIsRuB+4cCNV72FbwOy3QDw4gcqYIAPIFzIqh7CBQ66NJ6TQACeDMLO3ebzbwa90iEfQQf/JlBwE5y8f+fugKDbsOGfKjED5xalAQCZgQuU/NgRB8K9e1X0djmUB2N3WNnXcvYe7LvcCH/6CDRw7mB/oAMa4AC7cdtlu3pRiV6kcg7S/s2P0vRIbBcC4WmTElcgft4gp3YJfH0CuZvAA6IEQAc+4Iaq+x3hHnjkBjDw9REIHgeL91NZfmOzxAch9b9ZvTil1HYevJ3yThcBykswAWWEvvMmmMAFCB5zDmS9BHk3gKlPf4PUt2vtkH99vKsG/drv4Pb1rrMwEoCBcxuA3cn/QOl9GwTm22DoZEcB0IWAfrWr/+jlTzq2b/4HU+fA/DXYeAw+LnGKMzvjQPB2GbB3/0aBfzQAb/hGf9LgfCkwbwqoA2+HWDk3BND2AtJGgf63Ahc4BBG4CBswAQHgAZnUa+s2AsEmAtsmeQs3BLTmAgxwayzoai4Igxwof41AARxQbMInZBdVASoXcxS1e2G3gkMgaixQakZghJ32aY5lg4zwAZSUSj91cECoe3pkgDYAadPXLpOGBFroNl3YhCroCANQei21AReQSQaQQwFAc2MIdkXgZ/0BaAegZ+QWh3U2h3hWh1MnhgTGcoDgUAFwAQaAAaUUcx7gax5whRN4BAmwZmdWAQ84BI9oZnfUZknQgYlwAXvXUlvHcFb4hqYHiLrlhBEmfiIASGd4AUKkRP9C6GONGGYwJwkBYHxriHMi0HVYF4SM6G5cBou/OIuyCIeF5ovDOIrBSIxw9ofJiIwTZooXgoUFCI1LZozLaI2pho2Xpo1VNoTFyIzH6GVORo3wIY20RY5axo1QJooSqI7HBImXKInWhY5GYYkDoEglYI/4CAZyeGe/EWh3uAX6iAIDKUGDhEecVwIHeUcJ+QVfuGiNBgYLOQANqZB+VJEcoml49HIkoJF3xJFdoISkxoRe4JF/hAImCZIcYkd4RIAseUcEmAUt2AIvGJBX8JIDEJMAgJM6CR+S1Eko8JPwxwUVyGzO1gRCqQJJyUGXNAAAOHd39JQuxYBuk29d0JT/UgmVThlCiESSJtCV9mcF+mcCHWcC/McFYKkCaRlCmJQCbekF7ddz7/cFb+mWA2CTF2IAP4gCegkGDFgTVSlce5kCfVlRmedjh9kFqecKjVcrS2N9VRAAiYmYQ5QBh4gClumX0xd7aNN60dcFmbkCoclPPfCX1UeajRCXDDWXqLkIY2mBWclKATabnoADCFgPVml7tIlfb8AkovWbwNlQOVCULbCBaBecyLkLkEkGy9kGzckCM3mENIh2bvCcYWCdaoCdKiCSKYCEP6CditmbeQCeKfCQkhaRYled4okH5JkC/UiHdqh46jmfd9CeDQGPnSSPQ2CfWcCf/dkC3EQC//jQLkYQoDXgn1VgfQMqoGnjBDZSUuvZabUGU7jjAtZJOc3HBtb3AIPFG5ECFiuAVTxwJRBKnz0SIDYDUwIgKs/CJ/QwE4BZEp8xbwJwFTL6Jx/BabeyK68yGEKxdianoQ14ADOiVecBF60CLnviL7wBM+5wJ/FQEnXiozLToo5yHimRP1lVos7JAhBAOewSHYayMixiEd0BNWzhFl6xplLzKEZyL+ZSUI3BMCFhAXnBAghKBbX3GA3QeqoiGAUgKmDzUQNTMAiwLMXSDmFTp3dqpmbiABwhFs9SpLlnog0YbxQKEMizTr8BEI/RERyxGJ96E6GKM9ZBIMbwABIwe/9ctQbWV3YgsaJaURCCIQKCsSYT4wrMsy1Eo6ritKkrSgAMYC0hg3hBaqlug6lVRRzgwnpvgzPfcxyhc6rSQTIZ06rZqQKwqqQjxVOP8zPelDcFsi0WsxErEjsM8DEd5ZYRqgK38nP+YQwE8E4C1B25gR2aURXxgK+gY6r6wRkFEWlcmgavegJeIqbOURI3MSOGAzqxI68iEBUCUK+28hw12qHH2qXyFm8GEiAtgzgSACDiAhwQUj0Qcj78ATce9a+XwR+UOrBYgAEf4AE9WVYpAKtp0hvik6/zoxnAIzzvEz9Y4bLPIbLqBCDREz3YKqQbm61bwGYVMAE2WbBVEED/VNKuKaBA2bmbpeBHfsQBGnCZJHUCGPsEWru0rjqeXEsKXotHF7V3eZqgWEsHcat4eAS2YlsCdTsFe8u3JdAApWErBKAjOCIACzQDmUUZKyAQWwg8QNK3P4BDUounMQAvRbCgMQC5UaBP3hIP8YQ8XYMbEAA2GVp5NpsCxYECR5OxBBsDDnCtiLuFJkAkMqC5UKBPNbo2UcEAenEeNzuln9IbMOFpSDOjBFUVOfpNU3oYNrEqelEwrIsG2MkVDEAmwZsQwzsRlhK4K7QWJiECH2EqI3ETLvoCtvsE+rRsa4IXsKsCiIo1AhIvjgoXa9oVbVouWHEV70s3/EJAHRO9/2eAneBhEXTyIoJxFj7CHgOAIJDqLeBSv/ACNZriGNwSpldrogcRTyBBKDpVtrkqnDTjHLMxqrZTJaHzwdADMg5SKKfbuhZID7WDEwTxGdlBKH5jDyQcAQpgAeAyHSvTKjBwvk6gTxlcMBOBF4VXUt5EM0u1JtJqs9LqTVyzwls6ttL7Ao4TIBYgp9MhHFRzw0VzHEc7OgRSNkBaqRrLwmglL3YCGSnqE/RAM8sSNYPhNfkKO85iHXDMv7JhUy18xS5gHs8iIcdBH+YhHoQCHabCr9xEx9exOYmLxkwbMn/iczrFJ/YQL4cSPAdAyHDDEjBTHSnbEUTqM+fByUmjwv99nLt/HMAvPAIWs6Ldg6UHQh7Ukz/bU7LNK7Kzij1tZb7t6h0wEAG9awXr2spmwJ8iKslGIMRNsFASUGva2npU4C0W7MxJoMxnzFNHgM1L4M16Oslpi6xzAM7NTM6AXJ/i7LRpbAfmXATvfM7oHAfxvJ/znMzJeQu+mc+0UM+Kx88APQv+DHK7CXBcywYAdm4Apg0DrQriCAkNTV6kKEERTYsTbSIVrV4XHSIZDQkP/QgdDV8bzSEhzV8jfSElbWAnTSEprWFl1NIRttLwAdOK8NFkyEU23Qg07WEyrRw7jWI9jRo/jV73pdD3BQ5DDQYJcAFr60/nhtTU8IrcFdT/gRjVR2kFOe3K0SDV4kXVf5DUwnTVkenVfgDWXsDVRA3VWy3WVJDVyWzVvkXWfWDWx8TWU+DWZUDXXIDW7iXXeRAAXhuWi/ABXluzWlCQy8BJfjR+j+ABfrSPYjCRGDkMX3sMOBmbXJCS1EDYdzSZkmCJgq0FPEkNjn1Hk+iaeISXXbCU0ZABeOQMGjmUYoCV2oABeuYMjRRKZ7CW1DBIKqkKkpS3YpDbqi0JmmbYjnBJjM1bgxkNrQbXxOXZziDdDp0Go9ma2J3d2r3d0NXUPCTa3t0J9idf4V1Dp53NAZ3PQx1a6a0LpMVhNNXev1kAfj0Deg2zVTBZ0+Rj27wF/wJQ37Wr1Vig34yVQQHQ31rw31Zw36aLV8hhYgieBQout2/t4Ntg4BGOBRMezhU+4JGsWRhuBhvutyVQPx5RBAZq39H04UtwGgcu4gCeuSWgEYlCuitwsC2wJhh6oCueAjZSo9S8AimOAju+NCEeJj/iBJOifjEexALKHr/jvTRsKSFBvTaRpASgUziRKitBK4KLK6TDo9yRpTaz3pn1HzQxsTFQ5Ddbdi4OpPHEABnIrjyAF0F+E00OzN/0shCMv1nhwKMhKr96FSAqFgRjMDaBMMCjFXSKFZGqI2aOAtsxAvGQKjiRpDjyTdeEpU4hpfmzzHTF320esfaAE7eyKv82SlDveukL0MNQujTfS6NlO+JSgLs+l8Om7MXbpBGtgB1rkyOeksrSMawQgHiRLmlmSSqNISpIHC/HUegKFDAhAepvPurRYsppAQ944TiDSzO8ISr7OwIQzO2Hi+cLTgJnMeO3keuZkSkPwCi4wRxOHO/tQsbjARE9g8xT0A+4gy6Mae+LOjBy6uvnwat70ytHfgKybAGDEjrP+j2L0RsoTAK4/qp5bqGHku8KIBZ23K/NYiq34zWREhjcoU4zchy1wxG7URDLou+BBUI7vDRRkeS9MRU2zxhTIq4H31UQPuqG4/Cn8xZ1061SsyLwCq3aevEtsFBBgbSlPsqmvD3/vSHnfEIsSGsk9GM//JE/uwEhKArAY5VZVYoAfWqnMSKmA7PBjEHy5+E4D7vG+yTq6mcTU2EPGQM2ufHLeNw4EZ8Ze0w+oMHNJkDrmyvgmMVxVD8UhEE9+hEjr4Ez2CMg9SS01J7wg48T6NLq8OMWa/EPJkukU7E83fqznTzjUG/x597hh//gck8DFYoEhH+7hj9VLK4E1V4Dr38EsY++s5/ftZ8Et08Guz/EvR/2CmH5YjD8zyzfwXnsLcDmQRD8PAAmQ6D8TFDeOtTjLgDqxIT8jPX7N2D9lfQXXJ4R0awqKXGlzlu8jmnp7ur915u8VFopqAIq86oRZFIrtVIq//QPAgUDkIKIAItTCKQLCME707V947m+873/A4OARAF3aAAgC5Ni8QA0U0/Cg4B4KBQHBeJAAHgBkpaNYLgFyC/mwoJ0NLTcwnfwdjSn2OsCMGApQABcKfi9IY0lFVksIETQxAhJTlJWWl5WEt0sHKyRDZA0MBSAEhQB0EVIkNA5CQiM3pihqbm8koDCCESwmLTk3voBmJb8uhBIFFjUFQNYvAqAPkhYQcpgYmdrb3PXaJadNgtLMBSWntIF0xF4ERD0lZ3ZpEF+FsO6E5iLnzfnQhzoQ0eYLj/5vjhyYAHFmmvdHkKMKNHGtxoILBRCoCAYqAKCFPRDRQDCKS8X4f/BqzFrXi1+xagw7APMHjEwMkus6sKsYIFHKYaRCNNwItGiRjFVrAGwQIGN9pwUkBByoIQDDKqkOFDgQMsXK2vQm8GxWQOtBwTNxDXMwlZ7g7Q6CJMWQdwDDgDUXSXW4dG+fv9SDLeNIZYeX2mEBTwpkuLGjosm1fZgKxLD8sB2fcyDsebOnpEKfnx4RuLPOzibTq2aR2THo1+UXm0DtezatoeEdn0ZcebbMPj6Dv65dePXLmILpy18ueMED6BBjy59OvXq1l8x2E261/Xu3r+Dh1YAOPPyfykESK9+Pfv27t/Djx9gwo0E8u/jz6/ffQLz/v8DGKCAAxJYoIEHIpgzoIILMtiggw9CGKGEE1JYoYUXYpihhhty2KGHH4IYoogjkliiiSeimKKKK7LYoosvthgCADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CRH: corticotropin releasing hormone; TNF: tumor necrosis factor; IL: interleukin; PG: prostaglandins.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Lockwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_494=[""].join("\n");
var outline_f0_30_494=null;
var title_f0_30_495="Adult proximal humerus fracture 2";
var content_f0_30_495=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Displaced (two-part) proximal humerus fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 468px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHUAT8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxR7RlPSm+SynpXTtZhh0qB7LpkV2cp4/tDGRR3FP8gMDitI2PzcCui8NeEbnUJ1eRWSDPJI601G4ubqcbb6Nc3soS3iZifSt21+HV3Km64YJ7DmvadI8OW9lEqxxAY9q1JLFVUkiq5EiXWl0PCx8PI0+9uJqKXwOqj5UFex3kKrkhRisC+U5zhse1KyD2sn1PK73wbtTIArCuvDDITivWL23aQE7uK5u8tSN+Rk9qlxTLjVmup5rcaHcR5KrkVmzWksR+dCK9IlDoOV/Os68eFjsljH1rN00bwxMupwJBFNIrqrnTbWcbom2n0rHutMliJI+YVm4M6Y1oyMw0VI6MvDDFNxUmoyinUmKQxKSnYoxQA2ilooASiiigBKKU0lAwooooASilpKQgooopjCiiikAlFLSUAFFLSUAFFFFAH0RbaHdTfcgP1rXsvBc8zDzSFFenQ2KKRhRV2KBVPSvRsjwOY4zSvBVlbkNLH5jerV1drp0UKBUQADsBV8IoPApxB6AUxN3KjokYqjd7nBAFa3kbutO+yqBlhSEcxLZl1/8ArVmXlg2OVzn2rsLgxxDkjArndW1iytVJllUY7Um0Ujn57H5SpjBHqRWLd6bHJkbF/OptU8URuxW3zt9e5rj73XbpZG8hMe5qLlpMv3+i5Q7K5jUvD0pyy5IHNW/+Ek1EH5kRhU8HiaUsBcQjHfFItXRwV/bywSFRniqf2maPuT9a9Wlg0zWo85jWQ/ga5jV/BtzESbYeYtQ4djeFWO0jjmuY5RiaJT7iqssMLHMfFad3o11AxDwsPwrPktpU6oRWbT6nRFroym8W2oyuKuFWxyDTDEWPSpsaqRUK8U3FWnjx1FQlaRSZFRTytNIpDG0UtJQMSilpKAEoNLSUAFFFFAwoopDSAKKKKYBRRRSASilpKACiiigD9AglPWPJ6VZC0jnb2r0j50jEeDUm0DrioJZwgySBWZd6siZ2ncfalcZrSTRxqSxAxXM634pitgyW6+Y/14rN1O/uLjK7tqegrBuYmboOKlstIran4g1C6ZstsB/u1zl0rytmRix9TWzNCc8jioTbbiOKktGBJbkiqtxZE8musXTmf7qEj2qK70uQgEIRj2p2C5xUtowJAGTULWjdStdfJpu0bmB9+KqS2uCfT3pWGmcyLdo23Lla0rXWbi1x5jbl9DUl3b9gKzrqEeh4pD3NeTUdPvIi1wFVvSsa6h0qZjsmXPoRWdPal+gOapS2rrjgmldlJLuan9i2k5/dOuTUsnhyzgQmWVQcdTWVZSvbMzBjkdBU8l2LzAldg3oelK4/eXUzLzTrTzTtfKiqcttaQpwm4+5rRvAxG0Jx61k3Cv0NSzaDb6kKiAvgxrgUTJbycbAv0qJlIGcVG6sfpWZsl5lae22E7TkVWIrSVSThsmqdym1+KTRrGXQgpDTiKSpNBpopaKAG0UtJQAUUUUgCiikoAKKKKACiiigBKKWkoGff7X6qcdxTHumlHy8VE9vnkUJFtNeifPFa5gkkUkkms0we1dLGMrjFRy2IbleM0FI5eaD2qjLbFj0rq5tPJGMUlvpoUksMmlYdzkItIllbO3APrWja6NFGcyZY+9dK9uEHAqvJHnIANAXMzykQbY0UD2ptxal1G1RitGKHk4WpxENhHNAHOS2KMpVlGDWDqelQ/NsXB7V3EtsXOao3FhuHzUmhpnk9/ZyRyNxyKypoiM7hxXpesaQjKWU4IrlbuwjXI3AGoaLTOSuflUBVyD7VnzK5ztUD2rpLiyAz8wNZNzblSSKRSMeaIY7A96qOoBG0DNaMkJBOTVOWPnjiky0xolx1wcU1nhJ5QE1DIrAnb0qtI7Dp1qWy1EvrFYscSAofUU2a20tRzcHPpismSRyDzVOZ/ck0nIuNNvqX5rmyiJ8sFyKwpm3uW9akYZNRlazbudEIqJERSEVIRTSKk0I8UhFPIppoGNopaSgYlFLRQAlFLSUAFFFFABSUtFACUlLRSA/QoRo4yKUWwxwaYqsmAeKeHNeifPj0tsdBUvkEdqbHKwwe1WFm4yelAFaSE+maasRB6VfWVT2pwVGPB5oGZc9vzmqxt/mzW5NHgdMiqroKQXMsQAA8Y+lGzAwRV9go68VVuCgBPmCgZSbCnngVA2xz8x/GoLy5UZCksazGuCQdxqbjINZtg5IhlIzXn3iDTrmJmJdgexB6130r5yTyBVW5RLuExuo/rSsUnY8euHuImwztVdr2QfeGa6/U7MR3DxOoI7E1gajp4hBPr2qbFmRJeIeCgFVZJkY/KKnmgyelVJIOwFItWIJ34PTFZ8rDnvV57ZzwATTDp1ww+WFyPpUtNmkbIyJGY9OBVdkrZl064TloXH4VSkhZTgqQfepaZtGa6GcyYqNlq66YqFlqbGqZUIppFWGWoytSUmQEU0ipmFRsKCkRkUUp60lIY00UppDQMKKKKACkpaKAEoooNIBKKDRTA/RR0DL0qu0dW1GBTJUxz2r0D59EQUkAVKrbUwRkUkY7mnMu5sCkAqFTz0zUsaYOetROuwA1OmAmcmgZLuytRGINSgnGSaTcVOT0pAUryJgpwPxrkdVkk8x1DEAV3M7ApjrmuW1W0BZiB9KGNHPRTsX2yfnTpYz2ORTJYcMeuadbsy/K/SkUIsZIIYcGpo7VSpZeSKspHvwO9SzgQIFUDPc0AcDrNsGv2B9a5nWkzOUA4UYrstXwL13xWJ9gN9ctJ0j7mpKTOTi06S5k2xoc+vatS38NxKc3DFvYdK6lLeOGMLEoVRUciGgdzHXTbeEYjhUe+KhktzjAAra2+vNRPCCCccUCuc3NAxBBrNu7GORTvjU/hXVvaE5OKrSWZIPy0irnnmoaMnLRnafSufubZ42wy/jXp97pzFeEaua1CxPzBkytTKNzWFVrc4p0qF1rVvbbyXPHFUHWsmjrjK5UYVGwqww5qJhUmiZARTTUrCmEUikMNJTjSUDEooNIaBhRRRQAUlLSUAJRS0UAfo4U7ih0ynSpYxkAjvT9nBFd58+iio7VPFF3701Uw5FTPwvFAyvMMt7CnqDtApwGTk80/H5UARNTGycmnsDyBTCPl+tICCVsDGaz7pN4Prir8y84FVpRjgigZz9xb4OcZqt5PzYrcmiDA8cVXjt8tzSGQ2sZjjLsKz72TLGt27QJEEH41g3CZJxQNHMajC897tXhT1qfyBHEFQYArSNrht5HLUND6ipGY7RHuKilj74zWm0ZYn0qCROwoAzQjMflHHtU32fC/NirKp5fbFVrhjnOefSgCAxohOaqTCMnJNSSMSetU7n7vegZUvbnynwuSh9arv8AZ50KSoM46imXbbxgDp7VTDMhOaRRi65oJIZ7b507iuJu4GikZGBBFemJdlG+bp6etY/iDToL1fOi+Vu4FTJXNadTl3PPXWoWHFad7aPA5DDj1rPcVk1Y7IyuVmFRsKncVGwqTREJpKcwpppFCUUtJQMSiiigApKWigBD0ooooA/RrTJPMtlOecVeAyKxtGfZCAema20IOCK72fPkEgCsT61HgseelWLhM4qNFwaQxVTjGKUp6VIBzT8UrgVmTg8VCy89KuleKhZRmi4yjKvzcDiqsyncc81pOmRVaSPk0wM9o/WhY8EcYq06gcYqPBJIxQBnXoyxrLnjBbGOtbV0mXJrMmAEmO/rUlFZY1LfTimtErbiRVmGPB3EZyafPypIHFAGHJCEYlapSrhq17lARkdazphjr+lAyntMkgFQXCAMQauLkSZ9qqXSsVyc0gM+VeTxVW4jG3mrjEp9KrXPzglaBmJccE/lWdO4IxjFalzwTxmqU8fye9IpGJdZ7A1UlmIB+bFXrxCAayZxgEsBxSGijqOJImYAHHUVzlzEANy9PSuiHMu3OVPBrKvISqyjHANTJHRTdnYxnFQMKtOKgcVkdaIGphqRhTDUlIaaSlpKChKKKKACkpaSgAooooA/QzTBiJfQ1uW/3eaxtOGY1HoK2Lc4rvkfPksozimbamcdKAOeRUXKsMUYp+KUDmnYpNjSImFRMOasEVEwx2poGREZFVpV5q13pjrzTEUWTJ5qIp83FXnQ9qgdecUAZtwASayrlQp6Vs3IGTWXcrkGkMbGm2AHH0qGbBXAPNX1G+0Qjt1rPmIz70DKMiYyaoun3j/KtGZuoxVWZfk6YoAzXHzZzgVUupARjJrRkj3MFXqaq31sYOo5pDMmU8dDVd8nPOBV6ULs96oTZI46CgZm3ceSSOlZ8q/Ia1Jjjg9Kz51PSkNGNeLuU1jXCZJrc1Iqi7F6+lYd58pABpFIzwpE341VuF3GdT1xWgy/ODnkmqU3/HxJ9KTNEzm5Bgmq7irtyB5jY9aquKyZ2RKzVG1TPUTVJqhlJSmkpDENJSmkoGFFFFACUUtJQB+hWlPjA7VvRcgVzel8EA10Fu/IFd7PALq/Nx6UoHNMiOWzU5XNZPQ0irjMUYzTiKaSBSHawhHFRt705m4qItxVIliNgGo2Kg0jtVWZ8UySR5AM1E7Bl+Qgmqc249zVYO0Z4JpjLEyFiSazLshQQOtXTOMZ5rNuW3tkUgQ7TWO6SM9COKr3a8nA5otG2XAyetTXIEgI/iH60DMkqTIAfWpLmH5VA71Yt4t8vPalmXLmgDMihInGRTfESbUXjk1pxxjzQT1qn4oXCRmgDkWQ7jVW4TAq7P1JqjPk1JRRlXPvVS82xISBl/Srsvyg4+92qlNEdu5myxoGYNwp3l2+8axbwlmJI710M6bnINZtwqorbgM0ijNdcKrYrI1FgiseNzVeu7oqCFArDuCWJJPNJs0gu5Rl61WkFWpB1qu9ZM64lZxULVO9QsKk1RGaQ049aQ0ihhopTSUDEopTSUAFJS0UAfoXaxeWBWlExC+9VrdRjnpU0kgTArvPANG3I45q2pGKw1u1U9a0ba4WReDUSj1NISsWXNQM2DyalJyOaqzKQalBJis4qJmPWjkUHpVEETnioH54NWGHFQOOaYFZwOarSrVxxUMg46UDM6UVVcdqvzLVWRaQyk2VbI4IqUv5gDA/P6Ukq85qFQ3mDHBoA1raEGJnUfNjmqcke3NaUTeXbDnmo2VZhn+KgChEMyjiqnimLNqrelaGwpNTdbiMmnkY5xQBwTgEcjmq0qDnirs8DAbh+VVSA1IozngLMWJqrcxjay961HGKoXHJPFIDCniw24fSsTWcpHgda6eeM1zWvnsKRaOVuCTnNUJRWjcLyc1RmFSzeJRlHWqrirkoqrIKzN4lZxULCrDioHHNSzVERppp5pp60ihhopTSUDG0UtJQMKKKKAP0OkuViXrz6VSlvd3B71z8eovcEYPBqxA7NJya7zwbGh5jeZ8xPtWxptxtI54rJjXeMH8DVm1JVsUhnWRncuRQ65FU9OmONrH6VfNZvRlLVFJh2pB6VNOuOfWo+lUSRMPWoZFGasPzzUT9KYiqRUbjNTkYPSo3HHFAzPmXrVZxxV6ZaquODSGU3XNLbJ8/I6U8qSMCrNvDtG5uaAIrxiiKM0WcuWwehqC+YFzVWKVkkGDxQBsTRhiCKSdPMtiD6YqSA+agpSDgigRw15HsZx3rnp38uY+npXWa1+7uG4xnmuYnQyzMADSLRED5n3RnNVbtAo9K0SBaQkkDNZM8vnEtnikBRuDkYFcprhzIR3rrJwApNcjquWmOaTKRgTLwaz51IrVnXrWdcDFSzaLM6Wqkner0oqnKOahm8Sq1QOKsOKhepZsiA0009qaaRYw0lONNNIYhpKU0lAwooooA+utGvcFQTkV11o6sARXmWnSlXByQK7HRdQHCsc5713JnhtHXwHtV0LkAr1FZ1q4IB61pwHPWgRbtHIIrcjbfGDWAg2nI71sae+UK1Mthx3JpRlD7VW7VcIzmqhxkikhyGHkVC/Sp26VCwpkkD1E1TP1qF8UwK8ozmqrrVpznIqJwCOKQEECZkqzL8kRpkCHJOOKWZWbigZlyqXyaYsAU+tX5I9vFVmGDQMt2R21O4w+exqrENoU1O75xTJOd8SwYxJ2FYtvErjdjArqtfi82xkx1xXHQXyxQuj/eHSpKRla++CY1Nc1LKyKQDWvqchmmZj3rImXmkUjNmmkycsay7vLkk9a1bkA+tZs44PrSKMWdeTzWfOM9K17hOtZs460i4sy5R1qlKOtaEwqjNUM3iU3qB6sSdaheoN0QGmGpGqM0jRDTSGlNIaQxppKU0lAwooooA+lIj8yqh4rX0+XymHOaxW3QkbRx61ds5MkA12HinomiXYeMKx5rpbc5we1edaZceXg13OlXIliXB5qiWjcQBlx6Vf07gms+39e9alqu3n1pPYS3LJHNVZhhzVtqq3A+aoRciEk1GxqRuF96hJOKogiYc81DIKtEA1DIKYFRx6UzjPTipnHrULCkBp26o8OBiq80QUkYpllLsfBPFX5VDLkUAY0qVUkXB56VqTLgGqEq56CgYwONvNRGUBvakdcVHjnNAFmcCWAjGeK861i3MN1IuD1yK9EgIPymuZ8WWuCsqj2NJjRw9wvtWdOh5zWxOmOtZ9wvBpFIxbhazZ16+lbU6cGsy4GKRRiXA59qzrhetbNyoweKy5168UFIyZxzVCcVpXC4JrPmHNZs3iUZRVd6syjGaruKlnREgamGnt1pjVJohhpKcabSGIaSlNJQMSiiigD6aQB12sKswW23BUjFRxICQTxVyJW3cd67DxS5bHZgGun0OdlkXrtNc5awHIPOPSun0yHCqe1NCZ29jgopHNasPFYGkS4wjH6VvxHpilIS3Jj1qvP1FWG7GoJOTUoqRVaoj0qdu9RGqIGEVE/Wpu3NRSDnimBA461Aw9atMKiZRjmkBXJ2kEdq1bSUSRCsuQVJZyGKTH8JoGW7iPrVCdODWvIA65rPnXmgDNdMHmomTvVuReahK5BoAgiO16i1i2E9qw68VYYYPSpcB4cUAeX3cZR2UjkVmTrwa6jxBa+VeOQMKea52dOTUlGPOhrMuE68VuXCccVl3CZzQUjDulwDWXcL1rauk5IrMmTikUYtwvWs6ccmtm5TB6Vl3A61LRrFmXMMVVcVemFU3HNZs6YsrsKjNSuOaiapNUMNIacaaaRQ00hpTSGgBKKKKBn1dHb7gCMYPINaFvbKNpz0rC0K+IKxS9D3rq4IujLyK7TxCxaQAY3Ywa14E2ABelUIFywrYtlBAoEX7Q4II6101lJvQeo61zMAw+DWzZS7COaHqgNjPFQMOTmpVIYAimyjjNZop6oquOtRnpU71Cw5qyCNhxURxUzcioiKYEZHfFRt3qUjNNagCtIMjIqEgj61ZYZFQsKQzRs5A8Q5qO5Sq9lJskAPQ1oTLuSgDJkBquwINXplqq68UAQMuQTSRHBwe9PI4qPoc0AY/iW0MkJcDkVw9wmM16hdxiaBge4rz7U7YxTuh7GkxpmBcIMVlXK4JzW5OnWsi+XGcCkWjCuV5NZtwuc1rTrVCdcjpSGYtytZdynXitu4T2rNuU4NJmkWYsy9aoyjmtSdeOlZ8y81mzpgyo4qBqsOOtQsKk2REaaakNMNIoaabTjSGkMbRS4pKBn0rAmzDdDXUaHqQOIZDgdq5aGTcADzV6BSpyK7L2PFPQYccY6Vp2xHGK5nQrsMgjlPPY10UZ2iqJNLtkU6O5ydq/nVMS5AUVJGpVs9jQB1OmS+ZDgnkVcYZU1j6S+JQOxraHWs5blx1Viqw96iYcVO3BIqFqaIIGqM1K/SoD1qhCEUynMeaQ96AI2FQsMnJFWD0qFs0hkBJVwRWrbuHjBrLeprGTDFSaYE9wnNUpF9a05RuWqEwNICqRmomqZgeajIwOaYCRnIIrl/E9rgiRR9a6dGAbpVbVoBPbsPUUhnmtwvB4rFv1FdLfRGNmU9Qa5+/Hz4qSkYsycVQmTr61rSxs2SBwOtZ8ycnNIox7pKy7hOtbdyn5VmTpwaBp2MO5TGazJ15rbukwKyrheaiR0QZmyDmoHFXJBzVVxWbOmLITTDUhphpFjCKaaeRTTSGNNFFJQM+kEBQgHrV6B84x0pJDExCgc45NJAGRj0xXWeKa9nIU5Bwa63TL5bmAJkbxXCpIx4JrU02ZoplZcj1qkwO5hBrQgXKYrNsZFngVl5rTteOMUyTQsTskX1BroPQ1z0fDBq3oTuhU1EiojJh81QPVmftVZ+lCFLcgf0qFqmYd6YVFUSQnmg0EYNNJoACajbFPOaY1AyBx1qIEo4YdqmfpzVeSgDYiYOgPrUFynPFR6fISpHpVuVdy5FAGU4xn1qImrUy8+9VWBBoAjYDPHWnHDxkdxTWP50qH5sUAcb4kttjl1HWuLveZDXp+v23m27jHNeZXalJnU9jUspGZISucEgHg1RnFaEwOTVKUGkUjLuFz1rNnQc1rzjis6cUhmJdKcGsm5X2rdukHNZF0tTI2gzJlFVZKvyjmqkorNnVFlZhUZqVqjapNERmmmnmmmkUNNJS0lAz6aWLOGbrVsBGUIfzpkikH5elPiU9+tdZ4oLE0bAMPxq9BkkEflSwjzlw3anpGY2API9aAN/QbkwzBXPyNxXWx9QRyDXC2zgEYrsNFuBPCFP3lq0Szbt8MMVs2n+pxWLbcNgdK2rXhDUy2HHcfKPkFVmFWn+4aqv9aSCW5DJUR6VI9RnpxVEkLVHmnye1QOSOlAx2eaQ00HNL1oEMY8VBJyamaonGAaBjbd9ko54rYjbK+tYT8YNadjLvjHqKACdcZ4qlIOa1pkDLmqMqUCKLL3qM8c1YkXGRUL8CgZDeDfCTXmniW2MV4zAfK1emN9wg1yniSz82J+ORyKTGjzybvVOYZ6VenUq5B4IqlNxUlooTDmqFwOtaUuDWfcLwcUhmTcjjrWRdjitu4XrxWVdL1pM0gzFmHNVJBxV+deTVOUcVmzpiyowqJqmaozUmyIjTDUhphqShhpDTjTTQM+lNA1JZQsFyeegY1tGEq2O3Y1wdq7B8gV12h6gJVEF0fm/gauzc8axrQDYc1oKglTHGexqsFCfKw+lWrcDPXrQA2JSjY6EVt6TcmCVGzx3rOkiJUFRkjrU1qGDYpoR31thgrL0PIrbthiPmud8PkmEI/VeldHBwKUwjuK/3DVRzVuQ4UiqkppIJEEhNRE0524qBmxVEiO1V2OafI3HFVS/JoGTKwzjNOJ5x2qqHwc1MpJAoAcTTH6GlNNHegCBxzU1pIElAzwaY4qPIBB70Aby8iq86c0Wcu9BU8q5TNAjMlXmq0oq/KtU5BQMpzHCE1m38YkTnuK1JxhSO1UXG4Fcc0gPM9ftRBcsQPlNYM9eheJbISwOwHzDmuBuF2kg1LLRnTY59apTA84q7MCCapT+1IozbgEEisq6HJFa0/JNZlwOTQVEx5xyRVGUVp3C5JrPmXms2dMGUXHNRMKneoWFQboiNMNSNUZpFIaaaacaQ0ij3FFKPV+DO4EZzWw2jmVcpgN296ptbS27YdDkV1nj3Om0e4+2wBHOJkHfuK1oI8sAeD3rltNd0kR0BDg9hXd2MImgSfbgnqtUJj7eHfgAHFW4bQRSe3Wp4NuMheKupEHUevagRc0w7HUiukiPeubtBj61v2T7owD2olsJbk05wBVOXpVyXlaqSVKCW5SkwCagkNTydagYdaoRXlfAOar5BBqWcfLwaq5wTQMXmp42+X3qEdDT0OOaAJ+tB4HNC0NyDmgCNhUZHWpDmmsKAJrGTZJjPWtZTkVgqdrAite2k3oKAGXC4NUZhWpMMjNUJV5NAjNuOB7VSc7TmtC5XIOKziOxoGUdQjDxsMdq861y08iduOD0r02VcpjHNcr4jsxLAxA+ZallI88uBgVmz962byMgntism4UjINSyzLn61QmGc+1aM4rOmOM0FIzZ+prOmGGNaMxyTVCcck1mzeJQlHNQNVmYc1XaoZ0IhamGpGqM0ixhpKcRTTSKPrO3faVOODVieyEzb1bn0qrYYYgSHpWtaDbKvOVzXba54pQVfJ+QKAfUVr6PctDOAzZjbg1DdQBbgsPumnwKueRQgOsjQDH908irsC/lVDSJvPh8s/eXpWimVNMkmACnpxWlYSDdjsazwQ61Nav+8GOgoA2TVSYYJFWs8KfWq1wPmqENlGQdagerDjk1A9UIp3I/KqrDmrlwOKrkcUDGrjPNOPSkA5NOHSgBytwKdmouRTg1ADzTD0pTkimnNADGFWrCXBKk1XIzTEbZIDQBvcEcVTuFwamgk3qDSzrkcUxGRdD5TWUzc1sXanYayZRSGiNuT9azL+EHIIzmtLOetV7xcruHNAzzTXrQw3LDHymuauouteieIrUPAXA5HNcPcpnOagtM5u5XGRWdOM9a2byPGaxrjjOaRSMu5GCapSd6uXAyTVGX0rNnRErTDPNVXq1J0NVnqWbxIT1qNqkamEVJoiM0008000hn1pBEjIs0Ryjc1qQA4UVj+HdsAVJJAY27eldT9kWMCRTkdq7jxRoiEoINQrF5ZwefSrkI5z0BqSeDIDDtSGLYStC6spxXTIwkiWRehrl02r3rZ0a43AxN0PSmJmjG2DgcirEK7Xz2NQRqVf2FXFXK8dqBGnG2YlNQ3PODT7c5ixTZx+7+lR1GUH+9zUT1JJxUTHIqhFS546VB1qe55AqAdaBgaB7Up69KaTQAN60ikUjNkUDpQA/mg5xQOaKAGnpUZzUpqJutAFyxl/hrQzlawkco4atiGQFAc0xFO+XCmseQc+1b18uY+Kw5V5z3pDRW6EimMQVKmnseaY2CfegDF1CENG6tzkV55qUXlzOp6g4r0y8XrXEeJbfbIZAOtSykcbepkGufvFxkYrprhawdSj64qS0c9cZzVKT2q/cg5PrWfKahnTErSVXk6mp5Kgc1DN0QtUZqRqjapNEMNNNONNNAz6PsZZI2GGPFdzoGoGeHyZvvfwk1yKW6hxkYIrTsnMZBXhh0rtTPGZ2KSEttK4qwpY8ZqrZSLd26yjiReGq7GCAD270CKrxbX9jzmrNoTG4YdQameEOnA5HNMjoQHSxfvYVcdxVmDjANZ2kS5jMZrSjBDUMRct+hFEn3GBp0HSkfGGFR1GZso+Y4qAn0qeaqzHBqhEExzwaix+VOmPz1GTxxQMCajPWlyT1pKAGnmnA5FNNOBGKAHDgCl6igdKPagAzTGp5FMagCJ+Kt6fNkbTVJ85NMik8uVTnigDauPmjwKx7hcE1omUMBg1RuxzntQIzZOM4qFmxU0xqm7cHFAxtyAy5rmtftxJA3qBXSEg5yaytUQNG2O4pMaPMbobSQaxr4dRXQ6vF5U7jtmudvTknFSWc5fLhiR0rLmPNbV4M5rEuBg1nI6aZVkOagepZDxULHNQzoRE1RmnsKYak0Q00004000hn1jLaN3XDimQJtb5hXS39i2dyjkVlT2xJLDqOtdp4qZb0if7POM/dbrXUIoHK8qa5C25+Uiun0aXzYvKY8jpVAy6gwcUyaPY27sasBMj3FPKbo8UgG2D7JFPSt9cHBHQ1z1uh446V0Nj80QB6igTLsQwlNPenoeKic4PFSBRnqlLwfrV2c9aoynIpgVpjlhUZxjinyjjNR/WgYdvegHNGaaw4oAGpVoA9e1OTk0AOFBoFIeKAA9KY5pxPHWmE0ARP0NVJTxVlz8xqpMeOtAE9pdBsIeoq1L88ZrmWuTBeoT0bit6KYOnFMCjP8prPmfB4PWtG96msm4bBpAIzZ71DcDcpB9KY7jNJI3AJ5pDOI8UQYJcDp1riLxuTXpHiWPdExFeY32fMYe9Sy0Zl4eTisa5BOa2LgcGs2dfWokdENDKk4qJqszpg1WYVmzpTImpjU9qYaktDT0ptONNNBSPvq4tCRwtYV9YmNt6jjuK7bblfaqs9srggrmu1o8NM4GWAowkQfKetXdPkMcqsOoNal5pxR2CjKGqSWUsb8r9KEUdFGRIgdcc9aljQ9+lQaPGVUpKRWmyKo4FMRWMQVgccGr1kdpxURXetLCdpFIRpqcVHMcUqEFc1HP9ypGVJuhqhIauSng1RkNUBDL7VGRTpDnFIaQxhpSeKWkNAAORQDzTe9OPQYoAcDSnn600e9LmgBG+7UZPFK7Z4NRufSgCKQiqU5yKtSGqM7cHNAGDrLkMrehrY0a8823XnmsPXT+7B9DVfQbzZNsLYB6UkxnX3mGXI61iXLAZz1rU8zenBzWJfEiRs0xIqzSYJxSQz7htJqpO/NNimwwJpFCatFviOeeK8t1iMxXki9BmvXJwJIMj6V5z4ttSlwHA60mOJyEw6+lZ8y1pTDkgc1SnHPvUM3izKnHHvVJxWpOvBqhKtZtHRBlVhUZqV6iPvUGyGGm0802gZ+iUHHB6VIY+eKYoxU6Hsa7meGilPb7s5qm9sV681tsgI6VA0fPSkMwoCyTbu4rcQ74w1UbiAJJuXoauWTfLtNMZMFHGKgYbGqwwxUMoJGaBFq1YmI57UknKtUdmxyVp7dTS6gUZSMGqUh5NW5x1qjJjNAyJzkinZqNj8+BTs8UhiGkopKAFpD0pC2CaaWoAeWoZgBzTAc0yRuozQAvUcmmOfwozhetRO/egBsjdaoXLYqxLJWddOSDzQBkavIDA46muTiuniuVYHoa6i9GVORXG3oMdwy470ikei6ZdCWFT1yKi1Ne9Ynhi83IIyeRXQ3S74xmgRz06nP0qru54NX7tMOaoMOTSGX7Q7oyveuc8V2fm2zEDleRW1aSbJMfnS6rCJIWyOooBHj06YJyKozAAVsaunkXUqYwM1jTZNSzaJQmPoKoTDk5rQlFU5hWbOiBRcVCRVpxxVduKg3TIjTTTzTaRSP0TXgcVIvamKPWngV3s8MnUhhnvTWWmodpzUxHy5qRlKWPINV0YofTFXn6GqU67Wz60wLhOQD61E3pRbvuj2+lIeDQAlqcSVYkOGNV0+WWppTSAp3P3jWdMea0LrtWZcHFAyFj8/FSA8VWL/OKmB4oGKWppbFIaa1IBxamseOtNY4qNm60ASb6jZ+aaW4qtLKN2KYE7PjIzVeR8nims+RUTHigAY5HWq0w+U1P1+tRyDIpAY12hINcjrUe2cNjg1292uQfauY12DMZOOnNSykZukXJgu1PQE4rvYJBJFXmO7awYdq7jw/dia3XPUcU0EkTXqfNmsuZcHI4Fbl4o6isO7JBIoEQBwGBHar7nzrfjmshj8/vWlYybo2XNAHnfjG18u58zHB4NcpL6elemeMrPzrR2A5XmvNZhjioZtBlGUZqrKtXZKqS1DN4lGQYzVaQVclHNV3FQzeLKxFMNSuMVGak0R+ii9KcKXbnkUHiu88IXoafG2eDUJpQcGkMleqs67lI71a+8AahlXmkMqW52yVYk4IqCRSr+1TZ3Rg0wADJGKfIcU2Ic0kpwTQBXuT8orKuutadyQUrJujSGioWw1Tq3GKoTuUOakil3AHNAy2TTGOc1GZCajkkPrQBIzc1C7jnmoXlIzVZ5jnmgCw0meKru2G5pvmimM2aQFhTkUh5NJEPlpxpgNpGU4PNOAzSsKQFCdMjNYmp24eJlxXQyrwazrxAQRSYzzucbHIPY4Nafhq+EdwYs9aqa3btDds54Q1m2UphuVYHAzSKPT2PmR9c1k3aYJ4q7pswlgUg5yKS/jwM44pkmBIMZ7YqXT32ygZ602ZDk8VXXKyAjrQMv6rAJrdxjqK8g1OAwXMkeOVPWvaAd8IzzkV5r41svKu/NA4brikyoPU4+QZ6d6qyjHNXZFx1/AVWlHXjismdEWUZF4qsw9KuyiqrjNSzaLK0gGfWoG61accc1A4qWapn6KjrTZPWiiu08QaKQ0UUxj4iTkUPzRRSYyvOPlBpIOVIoooAmi6mmS/eNFFAijcdKyrrrRRQMy7vpUFq559jRRSKLQJxUcrGiigCrMxxVYsaKKQDNxxmliJZwDRRQBeHAGKeOooopgKetI3eiigCGQcVQuQMH2oopCOZ8QRI1uWI5FcU3DED1ooqS1sdp4XlY2wyc4OK37oboWzRRVEsw5QCSKz5ODgUUUhmnYnMQHasDxvChsGbHI70UUMa3PMZhjNVHoorJnRErSjjPeqziiipN4ldqhaiipZoj//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior radiograph shows a signficantly displaced fracture of the humerus at the surgical neck. In the Neer classification system this is categorized as a two-part fracture. The superior displacement of the distal fragment was clinically apparent as shortening of the upper arm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_30_495=[""].join("\n");
var outline_f0_30_495=null;
